Tag Archives: Health and Medical

Spodak Dental Group Provided Military Veterans and Their Families, and First Responders, with More Than $10,000 of Free Dental Care During Freedom Day USA 2020

DELRAY BEACH, Fla. /ScoopCloud/ -- Spodak Dental Group ("SDG") recently provided complimentary dental services to the men and women of the US' Armed Forces and their family members as part of the Eighth Annual Freedom Day USA. Freedom Day USA is a "Day of Free" to thank military personnel and their families for the sacriﬁces they make each day to ensure our freedom. In an effort to also thank those who are at the front lines battling the COVID pandemic, the team also invited first responders to participate. In total, 14 patients were treated at no cost during the event.

"Unfortunately, highly-skilled dentistry is not always accessible to members of the military for many reasons," said Dr. Craig Spodak, owner of Spodak Dental Group and National Committee Member for Freedom Day USA. "We consider this an honor and a duty to take care of our military members and our first responders by providing exceptional dental care to them and their families."

The year, Freedom Day USA was held nationwide on Thursday, October 8, 2020. In honor of this day, Spodak Dental Group provided first responders, veterans, active military members and their families with more than $10,000 in total dental work, including free cleanings, exams, fillings, X-rays, treatment for tooth pain, and extractions.

Dr. Craig Spodak, who sits on the National Committee for Freedom Day USA 2020, and his team have participated in Freedom Day USA since its inception. They were the only business in Delray Beach that participated in the event.

About Spodak Dental

The Spodak Dental Group, a 2017 Inc. 5000 honoree, has evolved to become South Florida's premier, comprehensive dental facility, and comprises a world-class association of dental professionals poised to provide full-service dental care second-to-none in both scope and skill. The Spodak Dental Group team includes General and Restorative Dentists, Endodontists, Periodontists, Board Certified Oral and Maxillofacial Surgeons, Master Ceramic Artists and Anesthesiologists, as well as one of the nation's only in-office dental labs. Spodak Dental Group is located at 3911 W. Atlantic Ave. Call or text (561) 303-2413 or visit https://www.SpodakDental.com/ for more information.

VIDEO (YouTube): https://youtu.be/4WSWJ55-2BY

Spodak Dental Group ("SDG") recently provided complimentary dental services to the men and women of the US' Armed Forces and their family members as part of the Eighth Annual Freedom Day USA. Freedom Day USA is a "Day of Free" to thank military personnel and their families for the sacriﬁces they make each day to ensure our freedom.

Related link: https://www.spodakdental.com/

Healient Physician Group Forms Agreement with New Frontier Mobile Diagnostics

KANSAS CITY, Mo. /ScoopCloud/ -- Healient Physician Group and Kansas City's newest Medicare-approved diagnostic imaging vendor, New Frontier Mobile Diagnostics, have announced a partnership to improve access to care for seniors put at risk by the Covid-19 health crisis.

According to the CDC, 41% of adults in the U.S. have delayed or avoided medical care due to fears of exposure during the pandemic. The aim of the partnership is to bring high quality, life-saving diagnostic services directly to patients in care facilities throughout Kansas and Missouri.

New Frontier uses portable ultrasound machinery to provide in-room diagnostic imaging services for heart, vascular, and general imaging procedures. By eliminating the need to transport patients to hospitals or imaging centers for these procedures, New Frontier minimizes patients' risk of exposure, improves outcomes, and lowers costs.

Healient Physician Group provides the diagnosis and treatment of select healthcare specialties, such as conditions of the heart, wound care, and various forms of vascular disease. Often, these conditions are prominent among patients in long-term care or skilled nursing facilities serving seniors or individuals with disabilities.

"By partnering with New Frontier, we're helping vulnerable patients minimize their risk of exposure to Covid-19 by bringing trained healthcare technologists into their care facilities to perform diagnostic procedures," Said Dr. David Burkart, principal of Healient.

"Obviously, senior care facilities have been overwhelmed by the demands of the pandemic, and they are working hard to balance the ongoing healthcare needs of their patients with the realities of the virus," said Jeff Blackwood, CEO of New Frontier Mobile Diagnostics, which started procedures in July 2020 as cases of Covid-19 rose worldwide.

Access to care remains a significant problem for Americans, according to the American Heart Association. "Our first goal was to help the senior care community, since the pandemic had the greatest impact on their access to care," said Blackwood.

For more information on New Frontier Mobile Diagnostics and its services, please contact Jeff Blackwood at info@newfrontiermd.com.

About Healient Physician Group

Healient Physician Group is Kansas City's leader in the diagnosis and treatment of select healthcare specialties, including conditions of the heart; traumatic, diabetic, and post-operative wounds, and various forms of vascular disease. Founded in 2013, Healient's patients have come to expect excellent experiences and people who care about people. For more information, go to http://www.Healient.com/.

About New Frontier Mobile Diagnostics

New Frontier is the Greater Kansas City Area's newest Medicare-approved provider of in-room diagnostic imaging services for heart, vascular, and general imaging procedures. Our partnership with Healient Physician Group ensures informed, professional analysis, bringing patients access to quality diagnostic care, when they need it, where they need it. For more information, go to https://newfrontiermd.com/.

Healient Physician Group and Kansas City's newest Medicare-approved diagnostic imaging vendor, New Frontier Mobile Diagnostics, have announced a partnership to improve access to care for seniors put at risk by the Covid-19 health crisis.

Related link: https://newfrontiermd.com/

AMI Expeditionary Healthcare Contracted by the CDC to Study Spread of COVID-19 on University of Wisconsin Campuses

RESTON, Va. /ScoopCloud/ -- AMI Expeditionary Healthcare (AMI) is contracted by Centers for Disease Control and Prevention (CDC) to determine the prevalence of asymptomatic COVID-19 carriers on college campuses and what can be done to slow the spread of the disease.

The CDC, based in Atlanta, Georgia, is contracting AMI to bolster COVID-19 testing sites to obtain blood samples of students from the Madison and Oshkosh campuses of the University of Wisconsin.

The CDC will compare the new samples with samples taken at the beginning of Fall semester in September. The findings will help answer the question of how long antibodies stay present in the human body and whether these antibodies could protect individuals from reinfection.

About AMI

AMI Expeditionary Healthcare is nationally and globally distributed. Physician-owned and physician-led, AMI has been providing healthcare solutions for over a decade in some of the most remote, challenging, and under-resourced environments in the world.

AMI has delivered countless healthcare solutions and more than 7,000 medical personnel to upwards of 100 clinical and hospital settings on four continents. AMI is headquartered in Reston, Virginia.

CONTACT INFORMATION:

Dr. Andrew Walker, Founder and Executive Chairman, AMI Expeditionary Healthcare LLC at

1-703-996-6821 (mobile), 571-375-8366 (office) or andrew.walker@ami.health

If you would like to learn more about AMI and their services, please visit https://ami.health/

FOLLOW ON SOCIAL AT:

Facebook https://www.facebook.com/amiexpeditionaryhealthcare

LinkedIn https://www.linkedin.com/company/amiexpeditionaryhealthcare/

Twitter https://twitter.com/amiexphealth

Instagram https://www.instagram.com/ami.health/

MULTIMEDIA:

*PHOTO link for media: https://www.Send2Press.com/300dpi/20-1201s2p-ami-cdc-campus-300dpi.jpg

*Caption: AMI Expeditionary Healthcare (AMI) is contracted by Centers for Disease Control and Prevention (CDC) to determine the prevalence of asymptomatic COVID-19 carriers on college campuses and what can be done to slow the spread of the disease.

AMI Expeditionary Healthcare (AMI) is contracted by Centers for Disease Control and Prevention (CDC) to determine the prevalence of asymptomatic COVID-19 carriers on college campuses and what can be done to slow the spread of the disease.

Related link: https://ami.health/

Premier Nursing Academy Launches New Center to Train CNAs for Free and Grow Bradenton-Sarasota Area Healthcare Jobs

PINELLAS PARK, Fla. /ScoopCloud/ -- Premier Nursing Academy, an institution offering free, state-approved training to become a certified nursing assistant (CNA), has launched its second Florida location in Bradenton. The new Bradenton location is expected to train as many as 500 students in 2021 from the broader Bradenton and Sarasota metro area.

This new campus makes Premier Nursing Academy's innovative no-cost training model available to more students and progressive healthcare employers. Premier Nursing Academy works with area employers who sponsor training and commit to employing candidates who complete Premier Nursing Academy's Florida Board of Nursing-approved CNA program. Attendees of Premier Nursing Academy do not pay any tuition or fees and are also guaranteed a CNA job upon graduation with one of many Bradenton-area employers sponsoring classroom seats.

Premier Nursing Academy's new campus location is 5720 14th St. W, Bradenton, Fla. 34207, in the Southwood Shoppes Shopping Mall. The first class at this location started on November 30, and additional classes are seated on a rolling basis thereafter. Both day and evening class schedules for 4-week and 6-week programs, respectively, are open for approved and sponsored candidates.

Interested applicants may view upcoming classes and apply on the Premier Nursing Academy website: https://www.premiernursingacademy.org/locations/florida/bradenton

"Employers we surveyed overwhelmingly confirmed their need for qualified CNAs in Bradenton and surrounding areas, including Sarasota, Sun City, and Palmetto," says Matt Killday, Chief Operating Officer. "Local healthcare facilities could collectively employ 1,000 or more CNAs in 2021 if they had enough qualified personnel available for them to hire. What we're doing at Premier Nursing Academy is working with employers to identify promising talent and provide them training for free, to get more people certified and into these skilled local jobs that might otherwise go unfilled."

Premier Nursing Academy's training program combines classroom instruction at one of its campus locations with onsite clinical instruction conducted at a participating employer-partner facility. Stringent COVID-19 protocols are in place at all training facilities for the health and safety of Premier Nursing Academy trainees, staff, employers, and patients.

"CNAs play a crucial role on the frontlines of patient care. We're doubling our capacity in Florida to train entry-level health professionals at a critical time," says Killday. "Our graduates-whether they continue to be CNAs or decide to go into more advanced nursing-are in a high-demand field and are making a difference."

Premier Nursing Academy was started with the goal of creating an training-to-employment pipeline and has graduated close to 1,000 CNAs since its inception in 2017. Founders Chris Palevich, President of Premier Nursing Academy, and his father Rob Palevich recognized a shortage of qualified CNAs in their area and set out to create a solution that could benefit both employers and prospective healthcare workers looking for a streamlined, debt-free pathway into the healthcare profession.

About Premier Nursing Academy

Premier Nursing Academy is a contract training provider serving aspiring healthcare professionals. Founded in 2017, Premier Nursing Academy offers an innovative no-cost training program in which trainees are sponsored by an employer and work for the employer after completion of their program. Premier Nursing Academy engages with employer partners by assisting them in recruiting and training new employees for entry-level healthcare positions or offering training to their existing workforce.

Premier Nursing Academy currently focuses on training certified nursing assistants (CNAs) in 4- to 6-week programs that prepare graduates to pass their CNA exam. Premier Nursing Academy operates training centers in Pinellas Park (Tampa metro area) and Bradenton (Sarasota metro area). Premier Nursing Academy is licensed by the Florida Board of Nursing to provide CNA training.

For more information visit https://www.premiernursingacademy.org/

Media Contact:
Chris Palevich, MBA, MSM
President, Premier Nursing Academy
Telephone 260-450-9647
chris.palevich@premiernursingacademy.org

Premier Nursing Academy, an institution offering free, state-approved training to become a certified nursing assistant (CNA), has launched its second Florida location in Bradenton. The new Bradenton location is expected to train as many as 500 students in 2021 from the broader Bradenton and Sarasota metro area.

Related link: https://www.premiernursingacademy.org/

Pure Protein, LLC Announces New Website Now Offering Its HLA Reagents and Technical Services to Researchers

OKLAHOMA CITY, Okla. /ScoopCloud/ -- Pure Protein, LLC (Pure Protein) an HLA company that has developed comprehensive analytical capabilities in the field of human leukocyte antigen (HLA) immunology and an approach to produce soluble forms of the HLA molecule (sHLA), is proud to announce the launch of its new website https://www.hlaprotein.com/.

This new ecommerce website offers academic and commercial researchers the ability to purchase individual HLA reagents to detect, profile, and monitor allele-specific immune responses, as well as HLA peptide epitope binding services to aide in improving the design of vaccination and therapeutic targeting strategies.

Rico Buchli, Ph.D., Pure Protein's Director of Research commented, "For over 20 years, Pure Protein has provided technology and expertise to advance novel therapies and diagnostic tools for applications in transplantation, oncology, autoimmunity, and infectious disease."

He added, "We are excited to now have a website where researchers can easily explore and purchase our inventory of over 250 Class I and Class II proteins in both unmodified and biotinylated forms and Pure Protein's peptide validation, screening and mapping services."

The website is a comprehensive source for HLA proteins, services and scientific resources that will be updated on a regular basis with new products, technical updates and company milestones. For more information visit https://www.hlaprotein.com/.

About Pure Protein, LLC

Pure Protein, L.L.C. is a biotechnology company focused on the development and commercialization of proprietary technologies related to the human leukocyte antigen (HLA) system, formed and exclusively licensed from the University of Oklahoma in 1999. Pure Protein, in conjunction with its affiliates and subsidiaries, aims to bring novel therapies and diagnostic tools to patients across a wide range of application areas spanning from therapeutic development in the fields of oncology, autoimmunity, and infectious disease, to antibody mediated rejection in transplantation. Visit: http://www.pureproteinllc.com/.

Pure Protein is funded and managed by Emergent Technologies, Inc. an innovation solutions and technology commercialization leader headquartered in Austin, Texas. Visit: http://www.emergenttechnologies.com/.

*LOGO link for media: https://www.Send2Press.com/300dpi/20-1125s2p-hla-protein-300dpi.jpg

Pure Protein, LLC (Pure Protein) an HLA company that has developed comprehensive analytical capabilities in the field of human leukocyte antigen (HLA) immunology and an approach to produce soluble forms of the HLA molecule (sHLA), is proud to announce the launch of its new website.

Related link: https://www.hlaprotein.com/

Spodak Dental Group Collects More Than 250 Pounds of Halloween Candy for Operation Gratitude

DELRAY BEACH, Fla. /ScoopCloud/ -- Spodak Dental Group and Operation Gratitude are teaching kids the value of giving back by donating their Halloween candy in support of troops overseas and local heroes. The team was able to collect more than 250 pounds of candy from local children and schools' groups, and joined the nationwide win-win movement for kids, parents, dentists and local military members and first responders.

"While we participate in many non-profit events and fundraisers throughout the year, Operation Gratitude's Halloween Candy Give-Back Program is one that is truly special to our entire team," said Dr. Craig Spodak, general dentist and co-founder of All-Star Smiles, a non-profit organization with a goal to eradicate childhood tooth decay. "While tooth decay is largely preventable, it remains one of the most common diseases of childhood. Giving kids the opportunity to donate their candy instead of eating it, and teaching them the importance of being thankful for their local heroes, is something we will always support."

Spodak Dental Group participated in the "Direct Delivery" program this year and was matched with West Palm Beach Police Department Community Response Division-HCGB 2020. A "Direct Delivery" is a meaningful engagement opportunity for donors to connect and personally deliver their candy to one of Operation Gratitude's registered military, veteran, first responder or frontline hero groups. These direct connections help to fulfill Operation Gratitude's mission of forging strong bonds between Americans and their military and first responder heroes through volunteer service projects, acts of gratitude, and meaningful engagements in communities nationwide.

Dr. Craig Spodak and the Spodak Dental Group team remains proud to participate in the Operation Gratitude Halloween Give-Back Program to reduce excess sugar consumption, prevent dental decay, and teach children the importance of saying "thank you" to all who serve.

In 2019, Operation Gratitude received more than 361,000 pounds of candy from more than 3,100 donors, and was able to distribute to more than 140 first responders, military and veteran organizations through care packages and direct deliveries.

"As we have all seen recently, the world can turn upside down in a matter of days. One thing that we can always count on during a crisis is our military and first responders on the frontlines," said the CEO of Operation Gratitude, retired Marine Lieutenant Colonel Kevin Schmiegel. "While they continue to serve, we will continue to support them with the help of this coalition. Together, we will deliver millions of critically needed items and letters of appreciation globally to the Frontline First Responders who need it most."

Candy and handwritten letters and drawings were collected at Spodak Dental Group, located at 3911 W. Atlantic Ave., the week of November 2 during normal business hours. Spodak Dental Group gave kids $1 per pound, up to 5 pounds maximum.

About Spodak Dental Group

The Spodak Dental Group, a 2017 Inc. 5000 honoree, has evolved to become South Florida's premier, comprehensive dental facility, and comprises a world-class association of dental professionals poised to provide full-service dental care second-to-none in both scope and skill. The Spodak Dental Group team includes General and Restorative Dentists, Endodontists, Periodontists, Board Certified Oral and Maxillofacial Surgeons, Master Ceramic Artists and Anesthesiologists, as well as one of the nation's only in-office dental labs. Spodak Dental Group is located at 3911 W. Atlantic Ave. Call or text (561) 303-2413 or visit https://www.SpodakDental.com for more information.

About Operation Gratitude

Operation Gratitude's mission is to forge strong bonds between Americans and their Military and First Responder heroes through volunteer service projects, acts of gratitude, and meaningful engagements in communities nationwide. More than 17 years ago, in March of 2003, Operation Gratitude sent its first four Care Packages to deployed Service Members in Iraq. Since its inception, the organization has given millions of Americans the opportunity to express appreciation through hands-on volunteerism and lifted the spirits of more than 1.8 million Deployed Troops, and another 1.1 million recruit graduates, veterans, military families, first responders and healthcare heroes. Corporate partners and grateful citizens from across the country donate more than 15 million "Wish List" and handmade items each year to fill the Care Packages. Through donation drives, letter-writing campaigns, craft projects, hands-on service projects, and other activities, volunteers are the heart and soul of the organization. For more information visit https://www.operationgratitude.com/, or follow us on Twitter at @OpGratitude.

Spodak Dental Group and Operation Gratitude are teaching kids the value of giving back by donating their Halloween candy in support of troops overseas and local heroes. The team was able to collect more than 250 pounds of candy from local children and schools' groups.

Related link: https://www.spodakdental.com/

Bright Road Recovery Contracts with Magellan to Provide Eating Disorder Treatment for Blue Shield Subscribers

CLAREMONT, Calif. /ScoopCloud/ -- Bright Road Recovery, the Inland Empire's Premier Eating Disorder Treatment Program, announced today that they are now in-network with Magellan Healthcare. This is good news for Blue Shield subscribers in the Inland Empire who are looking for help with anorexia, bulimia, binge eating disorder, or ARFID. Since Magellan is the mental health benefits administrator for most Blue Shield policies, many who have Blue Shield of California, or other Blue Shield policies, will have more access to excellent care, closer to home.

"We are so pleased to be able to provide services for more individuals in our community who are seeking help for their eating disorder," said Bright Road Recovery's Executive Director and Certified Eating Disorder Specialist Supervisor, Tamson Overholtzer, LMFT, CEDS-S. "The challenges of the COVID-19 pandemic have increased the need for support and treatment, and we look forward to being there for those who need us."

The pandemic has affected how everyone receives mental health or medical care; however, Bright Road Recovery was among the first eating disorder treatment programs to transition both their intensive outpatient and partial hospitalization programs to a telehealth format, maintaining almost completely uninterrupted services at the beginning of the shutdown in March.

"It was an amazing sight to see our team swing into action when it became clear that in-person programming wasn't going to be safe and a shutdown was imminent," Overholtzer stated. "We talked about how to make sure not to lose any of the effectiveness of the program, and then everyone pitched in to make sure their part was handled. We made the switch in only five days, and with almost zero glitches."

"We know that doing everything remotely on the computer is challenging and exhausting for everyone. We are proud of the ways we've kept the fidelity of our in-person program, so that there's no drop off in quality for our patients," says Katie Ingram, Program Manager. "We've also managed to keep many of the personal touches that help our patients feel connected to us and to the program. For patients who live nearby, we have daily meal pickups and a chance to receive materials for the day's group sessions--and for those who aren't nearby, we accommodate to make sure their needs are met in a different way."

While the Bright Road Recovery team looks forward to the days of in-person programming in the future, for now, they feel confident that they are providing excellent care of all their patients--including, now, those who have Blue Shield insurance---or other insurers who have partnered with Magellan for their behavioral health needs.

About Bright Road Recovery:

Bright Road Recovery has been the Inland Empire's premier eating disorder treatment program since 2014, providing intensive outpatient program (IOP) and partial hospitalization program (PHP) care. Bright Road Recovery also offers outpatient psychotherapy for individuals and families as well as professional nutritional counseling by registered dietitians.

Bright Road Recovery is accredited by the Joint Commission, and is the first eating disorder treatment center to receive accreditation from MET(T)A Protocol, which recognizes this program as having trauma-centered, mindfulness-based, EMDR-integrated program.

Located in the historic Claremont Village, Bright Road Recovery has easy freeway and Metrolink access. Parking is easy and plentiful in their private lot. For more information, please visit https://brightroadrecovery.com/.

CONTACT US:
Admissions:
Vanessa Lopez
909-624-7070

MEDIA CONTACT
Gigi Woodall
info@BrightRoadRecovery.com
909-624-7070

*LOGO link for media: https://www.Send2Press.com/300dpi/20-1123s2p-brightroad-300dpi.jpg

Bright Road Recovery, the Inland Empire's Premier Eating Disorder Treatment Program, announced today that they are now in-network with Magellan Healthcare. This is good news for Blue Shield subscribers in the Inland Empire who are looking for help with anorexia, bulimia, binge eating disorder, or ARFID.

Related link: https://brightroadrecovery.com/

OutcomeRx, a unit of CareMetx, announces First Independent Reinsurance Product for Rare Disease Specialty, Cell and Gene Therapies

BETHESDA, Md. /ScoopCloud/ -- OutcomeRx (ORx), a division of CareMetx, LLC, announced today a new reinsurance product to provide coverage access to high-cost specialty drugs including therapies in the emerging cell and gene therapy market(1)(2).

The Patient Access to Costly and Curative Therapies (PACCT)(3) carve-out reinsurance product initially provides first-dollar coverage for payers including PBMs, health plans and employers related to three costly therapies: Spinraza®(4) and Zolgensma®(5) for Spinal Muscular Atrophy (SMA) and Luxturna®(6) for Leber Congenital Amaurosis (LCA)-an inherited retinal disorder.

By offering a first-dollar coverage reinsurance product, PACCT provides payers coverage (without deductibles) for these therapies with the goal that payers will in turn lower the cost burden on patients with SMA and LCA. The new reinsurance product will be available with a coverage effective date of January 1, 2021.

OutcomeRx has partnered with Crum & Forster Accident and Health and IronHealth, a division of Ironshore to bring the reinsurance carve-out to leading PBMs, health plans, employer groups and benefit administrators to help change how high-cost therapies, including emerging cell and gene therapies are covered and reimbursed.

"We are excited to create this innovative reinsurance product in partnership with Crum & Forster to help ensure that families and patients needing these life-changing therapies are not hindered by the cost and coverage of treatment," said Mark Hansan, President and CEO of CareMetx, LLC. "We are confident PACCT is the most comprehensive and cost-effective reinsurance product to help protect payers from the sudden financial impact of the high-cost therapies needed to treat these rare genetic conditions."

Gene therapies are among the newest pharmaceutical innovations to treat and potentially cure disease. It is estimated that by 2025, 10 to 20 new gene therapies will be approved each year(7)(8). Today, the drug cost to treat a patient with these gene therapies ranges from $850,000(9) to ~$2.1 million(10), and future cell and gene therapies are estimated to cost $2-3 million(11).

Gary Nidds, Senior Vice President and head of Crum & Forster's Medical Business Unit, said "Our support for this program continues our tradition as an innovator in the accident and health insurance space. We are excited to sit at the cutting edge of coverage solutions for therapies that could, and likely would, otherwise be unattainable for those most in need."

Added Lainie Dorneker, President of IronHealth, a division of Ironshore, "We are excited about this opportunity to provide a much-needed solution to employers and patients and to partner with OutcomeRx and Crum & Forster in the pursuit of achieving positive outcomes and driving patient access."

"We invite all payers to sign up for PACCT as we have developed it as a carve out product available to all payers that purchase reinsurance, regardless of insurer affiliation, to help patients and their families have streamlined access to innovative SMA therapies," said Brooks Wildasin, Associate Vice President of Strategy for OutcomeRx. "The PACCT solution covers multiple therapies in the SMA disease state to ensure that most treatment journey scenarios are addressed, such as a need for both Spinraza and Zolgensma. Coverage will include a per patient per therapy cost limit for the two SMA therapies as well as for Luxturna and be available on a Per Member Per Month (PMPM) basis. We believe all types of payers can benefit from PACCT including health plans of all sizes, reinsurers, commercial group plans, and even state Medicaid plans that require financial risk containment."

Hansan added "Our team at CareMetx has been working for ten years with pharmaceutical and biotechnology manufacturers to help patients access and afford specialty therapies. Our division, OutcomeRx is creating the next generation of affordability solutions including insurance and financial products that are supported by both payers and manufacturers. We are really proud to launch PACCT and we look forward to expanding to other rare diseases that have high cost therapies, such as CAR-Ts and traditional specialty drugs."

For more information on the PACCT reinsurance product please contact Brooks Wildasin at admin@outcomerx.com.

About OutcomeRx

OutcomeRx (ORx) is a division of CareMetx, LLC formed in 2019 to address the patient, manufacturer, and payer challenges in the evolving Cell and Gene Therapy (CGT) market. CareMetx's founding team members have a 35-year commitment to helping patients through advocacy, services and technology. OutcomeRx represents the culmination of these efforts by creating next generation reinsurance and financial products that bridge the divide between drug manufacturers and payers. OutcomeRx, in conjunction with its partners, develops and markets financial, reinsurance, and warranty products that address the efficacy and actuarial risk associated with specialty therapies including Cell and Gene Therapies, while lowering the access and affordability burden on patients and their families.

Learn more at: https://caremetx.com/outcomerx/

About Crum & Forster

Crum & Forster,* rated A (Excellent) by A.M. Best (2019), is a national property and casualty insurance company wholly owned by Fairfax Financial Holdings Limited. Since 2000, Crum & Forster's Accident & Health Division has offered a robust portfolio of specialty insurance and reinsurance products nationwide, including medical stop loss, pet, travel and other voluntary and affinity benefits.

In 2019, following seven years of writing product in the captive insurance space, the division scaled to include international product capabilities through its wholly owned offshore captive facility, Crum & Forster Segregated Portfolio Company (SPC). Situated in the Cayman Islands and registered with the Cayman Islands Monetary Authority, Crum & Forster SPC is a Cayman Islands company that reports through United States Fire Insurance Company. Additional global relationships with other Fairfax entities provide our partners with even broader flexibility in underwriting solutions.

We place a strong focus on product development and creative distribution methods, along with excellent client service and support. The qualities and capabilities of Crum & Forster Accident & Health demonstrate our philosophy of building meaningful, long-term partnerships and our dedication to providing alternative strategies in an ever-changing insurance market.

Learn more at: https://www.cfins.com/

*Crum & Forster is a registered trademark of United States Fire Insurance Company.

About Ironshore Specialty Insurance Company

Ironshore, a Liberty Mutual Company, provides broker-sourced specialty property and casualty insurance coverages for varying risks. Ironshore is prepared to meet clients' complex needs promptly, with a local service and in-depth underwriting experience across a broad spectrum of industries.

Following Ironshore's acquisition by Liberty Mutual in 2017 and integration as a key part of the newly formed Global Risk Solutions, Liberty Mutual enables us to bring even greater scale, expertise, innovation and product offerings to market. As a combined operation with approximately $17.5 billion in gross written premium, brokers have access to a top-tier insurer with greater capacity and product lines for a wide range of risks.

Within the Stop Loss space, our mission is to be a leader through outstanding services, relationship building and innovative products. We understand that relationships are one of the driving forces in our industry today. We are committed to meeting the special needs of our broker partners and, most importantly, our self-funded employers. Through every step of the way, we pay great attention to details and respond promptly to all different aspects of the industry. When you partner with Liberty Mutual, you benefit from the financial strength, security, and capacity of a Fortune 100 carrier.

The information contained herein is for general informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any product or service. Any description set forth herein does not include all policy terms, conditions and exclusions. Bound insurance policies, rather than summaries thereof, govern. Not all insurance coverages or products are available in all states and policy terms may vary based on individual state requirements. Some policies may be placed with a surplus lines insurer. Surplus lines insurers generally do not participate in state guaranty funds and coverage may only be obtained through duly licensed surplus lines brokers

*Notes

(1) Not affiliated with any specific health plan or PBM and available to all financial risk takers.

(2) Availability subject to applicable state insurance department approval

(3) PACCT offered through OutcomeRx Insurance Management Services LLC

(4) Registered Trademark of Biogen MA Inc.

(5) Registered Trademark of Novartis AG

(6) Registered Trademark of Spark Therapeutics, Inc.

(7) Quinn, Casey, et al. "Estimating the clinical pipeline of cell and gene therapies and their potential economic impact on the US healthcare system." Value in Health 22.6 (2019): 621-626. Available at https://www.valueinhealthjournal.com/article/S1098-3015(19)30188-3/fulltext

(8) FoCUS Paying for Cures Toolkit. Expected availability to 2031. https://www.payingforcures.org/toolkit-overview/pipeline/ Accessed April 2020.

(9) Luxturna: FDA documents reveal the value of costly gene therapy. https://www.sciencedirect.com/science/article/abs/pii/S1359644618305282. Accessed August 2020.

(10) Sinal Muscular Atrophy Therapies: ICER Grounds the Prcie to Value Conversation in Facts. https://www.jmcp.org/doi/pdf/10.18553/jmcp.2019.25.issue-12#page=12. Accessed August 2020.

(11) Hopkins, Jared. https://www.wsj.com/articles/biomarin-explores-pricing-experimental-gene-therapy-at-2-million-to-3-million-11579190318. Accessed August 2020

MULTIMEDIA:

*LOGO link for media: https://www.Send2Press.com/300dpi/20-1119s2p-OutcomeRx-300dpi.jpg

OutcomeRx (ORx), a division of CareMetx, LLC, announced today a new reinsurance product to provide coverage access to high-cost specialty drugs including therapies in the emerging cell and gene therapy market.

Related link: https://caremetx.com/outcomerx/

Atlanta Nonprofit and Piedmont Healthcare Raise Awareness for Pancreatic Cancer Awareness Month

ATLANTA, Ga. /ScoopCloud/ -- November, recognized as Pancreatic Cancer Awareness Month, is an important time of year for Atlanta nonprofit Purple Pansies to raise awareness for pancreatic cancer, celebrate survivors and honor loved ones.

Pancreatic cancer is currently the fourth leading cause of cancer-related death in the U.S., yet only receives 6% of research funding. In comparison, the survival rates in prostate, breast and skin cancers are now over 90%, but a person diagnosed with pancreatic cancer has less than 10% chance of survival and this can be directly attributed to investment in medical research.

While the disease has received more attention recently due to many prominent individuals who have died as a result of pancreatic cancer including "JEOPARDY!" host Alex Trebek, Supreme Court Justice Ruth Bader Ginsburg and Rep. John Lewis, an increase in public awareness and research funding remain critical.

"Pancreas cancer is one of the most challenging cancers to detect and treat," said Andrew Page, M.D., director of surgical oncology and HPB surgery at Piedmont Healthcare. "Unfortunately, most patients with pancreas cancer already have cancer that has spread outside of the pancreas, making a cure uniquely challenging. At Piedmont, we seek to change this with a novel patient-centered approach. With hope and a plan, Piedmont can help patients and families overcome pancreas cancer."

Nonprofits like Purple Pansies are working with hospitals like Piedmont's and other research programs in hopes of ending pancreatic cancer. Last year, Piedmont was nationally recognized as an approved center for pancreas cancer care by the National Pancreas Foundation (NPF). NPF Centers are awarded after a rigorous audit review to determine that an institution's focus is on multidisciplinary treatment of pancreatic cancer, treating the "whole patient" with a focus on the best possible outcomes and an improved quality of life. Piedmont is the only NPF recognized center for pancreas cancer care in the state.

To learn more about Purple Pansies and how you can help end pancreatic cancer, including on World Pancreatic Cancer Day (Nov. 19), visit http://www.purplepansies.org/ and follow on Twitter, Instagram and Facebook.

MEDIA CONTACT
Beverly Rhodes
Maximum, Inc.
beverly@atlmaximum.com
404-771-6409

November, recognized as Pancreatic Cancer Awareness Month, is an important time of year for Atlanta nonprofit Purple Pansies to raise awareness for pancreatic cancer, celebrate survivors and honor loved ones.

Related link: https://purplepansies.org/

Leading Healthcare-Associated Infection Clostridioides difficile Symposium Focuses on Patients, Families, and Caregivers

TAMPA, Fla. /ScoopCloud/ -- C Diff Foundation announced today that the Inaugural Patient, Family, and Caregiver C. diff. Live Virtual Symposium will be hosted on November 23, 2020 at 1 p.m.-4 p.m. EST with keynote topic-experts dedicated in disciplines of healthcare, pharma, biotech, and academia. The event is complimentary with online registration http://www.cdifffoundation.org/

Presenters will deliver data and discuss critical information for an audience of individuals diagnosed and recovering from a C. difficile infection. The symposium was developed to increase awareness, expand the knowledge, and elevate advocacy skills through presentations focused on a leading Healthcare-Associated Infection (HAI) Clostridioides difficile Prevention, Treatments, Clinical Trials, Diagnostics, and Environmental Safety for Adults and Children.

C Diff Foundation expresses their gratitude to Seres Therapeutics for being the Sponsor of the Patient and Family Symposium and for partnering with the C Diff Foundation raising C. diff. awareness.

Seres Therapeutics partners with the C Diff Foundation to support this important event focused on the patients and their families who are so deeply affected by this devastating infection.

The C diff Foundation's Founding President, Executive Director, Nancy C. Caralla, a three-time C. diff. Survivor, devotes countless hours day in and day out with the members of the C Diff Foundation. As a global resource, the members of the C Diff Foundation are doing all that they can to support the educational needs of patients worldwide. It is through episodes on C. diff. Spores and More live broadcasts, the annual Symposium, and Conference that give a voice to the patients who have suffered through multiple recurrences by including these speakers in the section of the program entitled "Survivor's Journey." Only through the patient's eyes can we begin to truly understand their experiences, and the unmet needs.

About Clostridioides Difficile Infection (CDI)

Clostridioides (formerly Clostridium) difficile, also known as C. difficile or C. diff., is one of the most common causes of healthcare-associated infections in U.S. hospitals (Lessa, et al, 2015, New England Journal of Medicine). Recent estimates suggest C. difficile approaches 500,000 infections annually in the United States and is associated with approximately 20,000 deaths. (Guh, 2020, New England Journal of Medicine). Based on internal estimates including a recurrence rate of approximately 20%, we believe the annual incidence in the U.S. approaches 600,000.

About Seres Therapeutics:

Seres Therapeutics is a late-clinical stage biotechnology company with a strong development pipeline and rigorous scientific underpinning, working to revolutionize treatment of a wide range of diseases by modulating the function of the human microbiome.

About C Diff Foundation:

C Diff Foundation, a 501(c)(3) established 2012, comprised of 100% volunteering professionals is dedicated at supporting public health through education and advocating for Clostridioides difficile infection (CDI) prevention, treatments, clinical trials, AMR, Microbiome, and environmental safety worldwide.

Listen to "C.diff. Spores and More" Tuesdays at 1 p.m. EST (www.cdiffradio.com) sponsored by Clorox Healthcare.

Learn more at: https://cdifffoundation.org/.

Follow C Diff Foundation on LinkedIn, Twitter, Facebook

Twitter @cdiffFoundation #Cdiffpatientsfamily2020

Media Contact:
Kathy Bischoff
C Diff Foundation
kathy@cdifffoundation.org
Office: (727) 205-3922

*IMAGE link for media: https://www.Send2Press.com/300dpi/20-1119s2p-cdiff-symposium-300dpi.jpg

C Diff Foundation announced today that the Inaugural Patient, Family, and Caregiver C. diff. Live Virtual Symposium will be hosted on November 23, 2020 at 1 p.m.-4 p.m. EST with keynote topic-experts dedicated in disciplines of healthcare, pharma, biotech, and academia. The event is complimentary with online registration.

Related link: https://cdifffoundation.org/

Spodak Dental Group Celebrates National TMJ Awareness Month with complimentary TMJ consultations

DELRAY BEACH, Fla. /ScoopCloud/ -- November is National TMJ Awareness Month and the Spodak Dental Group team is offering complimentary TMJ consultations to help patients find relief for migraines and chronic headaches. According to the U.S. Department of Health and Human Services, an estimated 10 million Americans suffer from TMJ disorders, and the condition appears to be more common in women than men.

"Our goal as healthcare professionals is to provide the very best care to our patients and help them either get out of pain or avoid pain," said Dr. Tiffany Dudley, general dentist at Spodak Dental Group. "Most TMJ issues can be resolved with changes in habits in conjunction with a dental appliance, so it's important to discuss your options with your dentist so she/he can provide the relief you've been looking for."

Temporomandibular joint and muscle disorders, commonly called "TMJ," are a group of conditions that cause pain and dysfunction in the jaw joint and the muscles that control jaw movement. Common symptoms include pain or tenderness in your face, jaw joint area, neck and shoulders, and in or around the ear when you chew, speak or open your mouth wide; jaws that get "stuck" or "locked" in the open or closed position; clicking, popping or grating sounds in the jaw joint when you open or close your mouth or chew; a tired feeling in your face; trouble chewing or a sudden uncomfortable bite, as if the upper and lower teeth are not fitting together properly; and swelling on the side of your face.

TMJ often causes severe pain and discomfort, which can be temporary or last many years. It might affect one or both sides of your face, and it's most common among people between the ages of 20 and 40. However, most TMJ issues are due to parafunctional habits, which include clenching and grinding at night, and can be resolved with non-surgical treatments.

To schedule a complimentary, 30-minute virtual TMJ consultation, please visit http://www.sdgvirtual.com/.

About Spodak Dental

The Spodak Dental Group, a 2017 Inc. 5000 honoree, has evolved to become South Florida's premier, comprehensive dental facility, and comprises a world-class association of dental professionals poised to provide full-service dental care second-to-none in both scope and skill. The Spodak Dental Group team includes General and Restorative Dentists, Endodontists, Periodontists, Board Certified Oral and Maxillofacial Surgeons, Master Ceramic Artists and Anesthesiologists, as well as one of the nation's only in-office dental labs.

Spodak Dental Group is located at 3911 W. Atlantic Ave. Call or text (561) 303-2413 or visit https://www.SpodakDental.com for more information.

*VIDEO (YouTube): https://youtu.be/bdPCaSgS69E

November is National TMJ Awareness Month and the Spodak Dental Group team is offering complimentary TMJ consultations to help patients find relief for migraines and chronic headaches. According to the U.S. Department of Health and Human Services, an estimated 10 million Americans suffer from TMJ disorders, and the condition appears to be more common in women than men.

Related link: https://www.spodakdental.com/

Executive Intends to Stand on NYC Street Hugging COVID-19 Infected People

NEW YORK CITY, N.Y. /ScoopCloud/ -- New York based Best Virus Shields (BestVirusShields.com) is the manufacturer of a new "oral" COVID-19 respirator mask for use in high-risk environments, like sitting in an airliner cabin for several hours shoulder-to-shoulder with up to 300 strangers or visits to medical facilities. Today the company announced that its President, Thomas Leahy, would stand on 7th. Ave. at the NW corner of 42nd. Street from 10 a.m. to 2 p.m. on November 25th. and 26th. to demonstrate the efficacy of the company's groundbreaking oral respirator mask.

While stationed there each day, Mr. Leahy will hold a large sign encouraging people infected with COVID-19, the flu or a common cold virus to take a moment for a hug in the spirit of hope and for the benefit of science. Mr. Leahy states, "I will rely on well-settled science and the superior KN100 filter technology incorporated into the company's oral respirator mask to be protected against any viruses. Further, in preparation, I tested negative for COVID-19 three different times in the past three weeks at three different laboratories and I will retest again following this event."

This oral respirator mask, a device that goes partially inside one's mouth to make a perfect seal using one's lips rather than directly on one's face, is a giant leap forward in COVID-19, flu and common cold personal protection. This oral respirator mask addresses the biggest problem underlying most face masks. That problem being face masks are only fully functional (to their rated standard) if they are able to seal perfectly to one's face 100% of the time.

Today, few face masks have that ability because most face masks leak around the edges and bridge of one's nose to varying degrees. This leakage is due to faces being different sizes and shapes due to age, ethnicity, gender, weight and unique facial features. This leakage significantly undermines the effectiveness of a face mask. In fact, common surgical type face masks and many homemade or e-commerce sourced decorative face masks are notorious for leaks and are essentially just ornamental.

About Best Virus Shields:

Best Virus Shields, Inc is a new company formed in 2020 to develop products that use mechanical systems and advanced filter materials to protect users in high-risk or life-threatening environments. These include exposure to COVID-19, the flu, and common cold viruses, as well as wildfire smoke. (Thermally generated particulates.) Visit https://www.bestvirusshields.com/ for more information about our innovative oral respirator mask.

*PHOTO link for media: https://www.Send2Press.com/300dpi/20-1118s2p-virus-shield-300dpi.jpg
*Photo caption: Best Virus Shields oral respirator mask for use in high-risk environments.

New York based Best Virus Shields (BestVirusShields.com) is the manufacturer of a new "oral" COVID-19 respirator mask for use in high-risk environments. Today the company announced that its President, Thomas Leahy, would stand on 7th. Ave. at the NW corner of 42nd. Street from 10 a.m. to 2 p.m. on Nov. 25 and 26 to demonstrate the efficacy of the company's oral respirator mask.

Related link: https://www.bestvirusshields.com/

#2020EyesColorado Youth Art Contest Winners Announced

DENVER, Colo. /ScoopCloud/ -- 2020 Eyes Colorado and the Colorado Optometric Association (COA) announce the winners of the #2020EyesColorado First Annual Youth Art Contest. Students grades 1-12 were invited to submit 2D artwork while reflecting on the value of their eyesight through the theme, A Beautiful Sight. The goal of the competition was to engage Colorado students in understanding the value of their eyes and their own eye health. The COA sponsored public health campaign, 2020 Eyes Colorado, seeks to increase eye health awareness throughout Colorado communities.

The contest launched in January of 2020 and due to the pandemic school shutdowns, the entry deadline was extended to October 15, 2020.

More than 170 Colorado students submitted paintings, drawings, digital art, and photography from all over the state. Many participants shared powerful insights on vision that will inspire other students to understand the value of their own vision.

Angelina Blanco, Grandview High School Senior and winner of her age group says, "To see is to experience the world in all its beauty. Without my vision, I wouldn't be able to witness sunsets, rainbows, or the smiles on others' faces-my biggest inspirations."

One winner from each age group was selected based on scoring from the judging panel. Prizes include a $200 donation to each winner's school, the high school winner receives an iPad Pro, the middle school winner receives a SketchBox Premium Subscription, and the elementary winner receives a Green Kids Craft Subscription Box.

The #2020EyesColorado Artist Award Recipients*

Winner Grades 9-12:
Angelina Blanco, Grandview High School

Winner Grades 6-8:
Sophia Orishev, Campus Middle School

Winner Grades 1-5:
Maxim Furmanov, Greenwood Elementary School

*View artwork submissions and the complete list of winners and honorable mentions here - https://2020eyescolorado.org/art-contest/

Entries were scored by local Colorado artists; Matthew Lit, photographer, designer and educator; Alexis Davina, fine arts and portraiture; Julie Babcock, artist of unusual mediums; and Dr. Matt Buchanan, a local optometrist and COA Board Member.

"The level of creativity and depth of thought that these young artists put forth in their entries, is so inspiring. What an immense privilege it was to be on the panel of judges," said Alexis Davina.

Matt Litt explains, "I was continually surprised by the uniqueness and creativity of so many of the entries - especially from the younger artists! Many entries spoke of an inherent artistic ability. What a great experience this has been."

"What an honor to look at so much beautiful creativity and art! It was exciting to see all the different ideas and themes relating to their individual seeing experiences. What a pleasure," noted Julie Babcock.

Stay tuned for the #2020EyesColorado Second Annual Youth Art Competition in 2021.

About the Colorado Optometric Association (COA):

The Colorado Optometric Association (COA) is the professional organization of optometrists in Colorado. Over 600 Colorado Doctors of Optometry are voluntary members of the Association. COA has also launched a public health campaign titled 2020 Eyes Colorado - https://2020eyescolorado.org/.

Since 1892, the COA has assisted its members in providing the highest standard of professional care to their patients by sponsoring continuing education programs for doctors, advocating in local and state governments for programs and laws that represent patients' best interests, and providing information for the public. For more information, please visit http://www.visioncare.org/ or call 303-863-9778.

2020 Eyes Colorado and the Colorado Optometric Association (COA) announce the winners of the #2020EyesColorado First Annual Youth Art Contest. Students grades 1-12 were invited to submit 2D artwork while reflecting on the value of their eyesight through the theme, A Beautiful Sight. The goal of the competition was to engage Colorado students in understanding the value of their eyes and their own eye health.

Related link: https://colorado.aoa.org/

Tourette Association of America and American Brain Foundation Offer Clinical Research Training Scholarship, In Collaboration with the American Academy of Neurology!

BAYSIDE, N.Y. /ScoopCloud/ -- The Tourette Association of America and the American Brain Foundation have announced the 2021 Clinical Research Training Scholarship in Tourette Syndrome that aims to recognize the importance of good clinical research and to encourage young investigators in clinical studies related to Tourette Syndrome.

The two-year award provides $130,000, including a $10,000 per year stipend for tuition to support education and research-related costs for a total of $150,000.

"The more we understand about Tourette Syndrome and Tic Disorders, the better and more effective treatment and care become for the community. To support this, we are committed to fostering cutting-edge research," said Amanda Talty, President and CEO of the Tourette Association of America. "This important work cannot be done alone. It's our honor to partner with the American Brain Foundation to offer this prestigious scholarship in Tourette Syndrome study."

Recognizing the critical need for Tourette research, the Tourette Association of America has dedicated its grant-making efforts to further the commitment to make a profound difference in the lives of patients.

"This collaboration with the TAA will help better the understanding of Tourette Syndrome and provide crucial insights into many areas of the disorder, including prevalence and health risk behaviors associated with Tourette Syndrome. These breakthroughs can improve the quality of life for those affected by Tourette Syndrome now and in the generations to come," said Jane Ransom, Executive Director, American Brain Foundation.

Pre-proposals that describe the scientific basis and relevance of the proposed project are due on December 4, 2020. Full proposals from finalists will be due on February 1, 2021.

To apply, interested candidates are encouraged to:

1. Visit the Research, Grants & Fellowships Pre-Proposal form.

2. Select "Clinical Research Training Scholarship in Tourette Syndrome."

3. Follow instructions on how to apply.

For more information about eligibility and the award process, candidates can visit the Tourette Association of America website at: https://tourette.org/american-brain-foundation-partnership/.

About the American Brain Foundation

The American Brain Foundation, founded by the American Academy of Neurology, supports crucial research and education to discover causes, improved treatments, and cures for brain and other nervous system diseases. Learn more at http://www.AmericanBrainFoundation.org, or find the Foundation on Facebook, Twitter, Instagram, and YouTube.

About the Tourette Association of America

Founded in 1972, the Tourette Association of America (TAA) is dedicated to making life better for all individuals affected by Tourette and Tic Disorders. As the only national organization serving this community, the TAA works to raise awareness, advance research, and provide ongoing support to patients and families. To this end, the TAA directs a network of 31 Chapters, 83 support groups and recognizes 20 Centers of Excellence across the country. For more information on Tourette and Tic Disorders, call 1-888-4-TOURET and visit us at https://tourette.org/, and on Facebook, Twitter, Instagram and YouTube.

The Tourette Association of America and the American Brain Foundation have announced the 2021 Clinical Research Training Scholarship in Tourette Syndrome that aims to recognize the importance of good clinical research and to encourage young investigators in clinical studies related to Tourette Syndrome.

Related link: https://tourette.org/

Nationally Known Dietitian, Nutrition Consultant and Author Offers Readers A Path to Reversing Chronic Inflammation

SAN ANTONIO, Texas /ScoopCloud/ -- Jan Tilley, a nationally recognized dietitian specializing in chronic disease management, has just released a third book dedicated to helping those suffering with chronic inflammation. Entitled "Eat Well to Be Well: Living Your Best Life Through the Power of Anti-Inflammatory Food" (ISBN: 978-1626342668), the book summarizes the health risks so many face due to the fact the American diet has become completely unbalanced.

"I wrote this book prior to the COVID pandemic and recognize now how important the contents are as a resource to help people of all ages take practical steps to reduce inflammation. 'Eat Well to Be Well' offers readers a path to improved health by giving step-by-step guidance on how to maximize their health and avoid the compromised health issues associated with chronic inflammation. Those who read this book tell me it has been invaluable in guiding them to make healthy changes in how they eat, exercise, sleep and manage stress," stated Tilley.

As the world continues to navigate a very dangerous pandemic, news outlets throughout the U.S. broadcast story after story that the most at-risk patients are those with underlying conditions. The conditions they are referring to are a result of chronic inflammation which, if not reversed, can lead to diabetes, heart disease, various types of cancer, cognitive decline and a long list of auto-immune diseases.

Sadly, we have become a sedentary society, our stress is paralyzing, and proper sleep has become an on-going battle. Each of these topics are addressed in Tilley's book, both from her personal clinical experience treating patients and research from renown medical experts in these fields. Also included are over 100 of her most popular anti-inflammatory recipes deliciously designed to help readers successfully use food as medicine.

The book is available on https://www.healthbyjan.com/, https://www.jtawellness.com/ and on Amazon.

About Jan Tilley and Health by Jan

Jan is a nationally recognized expert in nutrition, general wellness and disease management. She is President/CEO of JTA Wellness, a San Antonio based clinic, where she and her team counsel patients to use food, exercise, improved sleep and managed stress to prevent or resolve chronic disease. Jan has years of experience in presenting science-based nutrition information to individuals and companies across the country. She has published numerous books on the topic of nutrition and has recently launched Health by Jan, a virtual platform featuring her blog, healthy recipes and personal motivation to inspire listeners to use food as medicine to manage chronic disease.

Jan Tilley, a nationally recognized dietitian specializing in chronic disease management, has just released a third book dedicated to helping those suffering with chronic inflammation. Entitled "Eat Well to Be Well: Living Your Best Life Through the Power of Anti-Inflammatory Food" (ISBN: 978-1626342668), the book summarizes the health risks so many face due to the fact the American diet has become completely unbalanced.

Related link: https://www.healthbyjan.com/

Brooklyn Borough President Eric Adams Gets with the PLAN Joins Health/Fitness Coach Marci Kenon’s ‘Check Your Risk’ Diabetes Awareness Challenge

NEW YORK, N.Y. /ScoopCloud/ -- Eighty-eight million adult Americans are on the borderline of developing type 2 diabetes and the majority haven't a clue. Marci Kenon, founder of New York-based Preventive Lifestyle Assistance Network (PLAN) has joined in a collaborative effort with Francheasca Roberson, executive director of California-based nonprofit The Eight, Inc., to break the chains that type 2 diabetes has on members of underserved communities around the country. Brooklyn Borough President Eric Adams also joins as an ally in the effort.

With November being National Diabetes Prevention Month, their "Check Your Risk" (CYR) Awareness Challenge hopes to encourage one million Americans to answer the one-minute survey of eight questions to assess their risk of developing type 2 diabetes. The survey can be found at https://www.checkyourrisk.org/survey.

With many not realizing that type 2 diabetes is not only preventable, but reversible with changes in lifestyle, especially nutrition and exercise, the team is poised to readily assist. Persons whose results indicate that they are at high risk will be invited to a free webinar to learn more about type 2 diabetes.

Kenon's organization, PLAN, focuses exclusively on providing the National Diabetes Prevention Program (NDPP), a preventative agenda helmed by the Centers for Disease Control and Prevention (CDC) to those in need. "With knowledge comes power," says Kenon, who was diagnosed with borderline diabetes in 2012 and attended a six-week diabetes prevention program. "I was stunned to hear my blood sugar was high. I had to practice what I preached to the clients I started to train as a fitness instructor the year I was diagnosed."

For Eric Adams, the Borough President of Brooklyn, NY, the endeavor is also personal. Adams was afflicted by type 2 diabetes at one time, even losing his vision. "There was almost a surrender to the disease until my vision loss," Adams recalls during an interview with the Physicians' Committee for Responsible Medicine. "That was a wake-up call. If I am going to lose this war on my health, it is not going to be without a battle." Adams conducted research and changed to a whole food, plant-based diet, reversing the symptoms of the disease that nearly robbed him of his driving rights.

The outbreak of the coronavirus has highlighted the pervasiveness of obesity and type 2 diabetes among Black and Brown people around the country. The CDC has warned that type 2 diabetes increases the risk of severe illness from COVID-19. Hispanic and non-Hispanic Black adults have a higher prevalence of obesity and are more likely to suffer worse outcomes from COVID-19. Racial and ethnic minority groups have historically not had broad opportunities for economic, physical, and emotional health, and these inequities have increased their risk of getting sick and dying from COVID-19.

Kenon and Roberson grasp the enormity of the diabetes and obesity problem, and it motivates them to do their part to impact the health and wellness of those who need it most. "There are a lot of resources available to the people we serve but they don't know these resources exist," cites Roberson.

With no end in sight for COVID-19 and the increasing cases of diabetes, the CYR challenge will continue beyond National Diabetes Prevention Month. The team is looking forward to working with Adams whose compelling story gives hope and guidance to concrete ways to prevent and reverse this devastating disease.

In addition to Adams, CYR has early support from the adult ministries department of the North American Division of Seventh-day Adventists, a Protestant denomination known for its strong emphasis on the importance of living healthfully. Their focus on proper nutrition, exercise, rest, and meditation are all major components of their Eight Principles of Health and in alignment with PLAN's overall approach.

"We look forward to reaching one million Americans," Kenon shares confidently. "Then the goal will be increased to reaching 10 million people. With 88 million lives at stake though, we are only scratching the surface."

Take the "Check Your Risk" Awareness Challenge at: https://www.checkyourrisk.org/survey.

Follow the PLAN on Facebook at: PreventiveLifestyleAssistanceNetwork (https://www.facebook.com/PreventiveLifestyleAssistanceNetwork/ ), Instagram at @taketheoneminutesurvey (https://www.instagram.com/taketheoneminutesurvey/) and on Twitter at @PreventivePlan (https://twitter.com/PreventivePlan).

MEDIA CONTACT
Makeda Smith
Jazzmyne Public Relations
makeda@jazzmynepr.com
323-380-8819

Marci Kenon, founder of New York-based Preventive Lifestyle Assistance Network (PLAN) has joined in a collaborative effort with Francheasca Roberson, executive director of California-based nonprofit The Eight, Inc., to break the chains that type 2 diabetes has on members of underserved communities around the country. Brooklyn Borough President Eric Adams also joins as an ally in the effort.

Related link: https://www.joinplanglobal.com/

AMI Expeditionary Healthcare LLC (AMI) Has Been Contracted by CDC to Provide Emergency Response Team Services in Support of the CDC

RESTON, Va. /ScoopCloud/ -- The CDC has contracted AMI Expeditionary Healthcare LLC (AMI) to provide Commercial COVID-19 Emergency Response Team (C-C19ERT) services. This work includes sample collection, logistics, and quality control metrics to ensure subsequent, high-quality, CLIA laboratory testing.

The C-C19ERT will be deployed as determined by CDC and work either in tandem with or independent of CDC in the collection, processing, shipping, tracking, storage, testing, and reporting of specimens suspected of COVID-19 exposure.

"These services will be critical to ensuring continuity of operations during CDC's response to the COVID-19 pandemic and we are honored that the CDC has chosen us for this important work," said Dr. Andrew Walker, Executive Chairman of AMI.

Dr. Walker went on to say, "The unique nature, scope, and complexity of the scientific, technical, expert, operational, and logistical services needed will vary, from site to site, in an effort to support remote COVID-19 sample collection."

About AMI

AMI Expeditionary Healthcare is nationally and globally distributed. Physician-owned and physician-led, AMI has been providing healthcare solutions for over a decade in some of the most remote, challenging, and under-resourced environments in the world. AMI has delivered countless healthcare solutions and more than 7,000 medical personnel to upwards of 100 clinical and hospital settings on four continents. AMI is headquartered in Reston, Virginia.

CONTACT INFORMATION

Dr. Andrew Walker, Founder and Executive Chairman, AMI Expeditionary Healthcare LLC at: 1-703-996-6821 (mobile), 571-375-8366 (office) or andrew.walker@ami.health

If you would like to learn more about AMI and their services, please visit https://ami.health/

Facebook https://www.facebook.com/amiexpeditionaryhealthcare

LinkedIn https://www.linkedin.com/company/amiexpeditionaryhealthcare/

Twitter https://twitter.com/amiexphealth

Instagram https://www.instagram.com/ami.health/

*PHOTO link for media: https://www.send2press.com/300dpi/20-1117-ami-cdc-andrew-300dpi.jpg
*Photo caption: Dr. Andrew Walker, Executive Chairman of AMI Expeditionary Healthcare.

The CDC has contracted AMI Expeditionary Healthcare LLC (AMI) to provide Commercial COVID-19 Emergency Response Team (C-C19ERT) services. This work includes sample collection, logistics, and quality control metrics to ensure subsequent, high-quality, CLIA laboratory testing.

Related link: https://ami.health/

Zeteo Biomedical to Collaborate with Iowa State University Nanovaccine Institute to Study a COVID 19 Vaccine Under Fast Track CARES Act Funded Program

AUSTIN, Texas /ScoopCloud/ -- Zeteo Biomedical LLC, Inc., a privately held medical device company, has partnered with the Nanovaccine Institute at Iowa State University to study a nasal SARS-CoV-2 vaccine. Zeteo will provide nasal delivery device technology and unit dose packaging utilizing its ZEOx2(TM) Delivery Platform, along with technical services to support the evaluation of a room temperature stable SARS-CoV-2 vaccine under development by ISU's Nanovaccine Institute.

Zeteo ZEO(TM) Delivery Platforms provide nasal delivery device configurations to support vaccine development during early stage pre-clinical animal studies, human clinical trials and are commercially scalable to fill/finish and deliver millions of doses per day for a global supply of nasal vaccines or medical countermeasures in the event of a pandemic crisis.

ISU's vaccine is expected to provide long-term protection against SARS-CoV-2, the novel coronavirus that causes COVID-19, and is intended to address some of the limitations of the vaccines currently in development by targeting room temperature storage and single dose nasal self-administration as key capabilities.

"Our approach leverages the strengths of ISU's nanovaccine platform and Zeteo's ZEOx2 nasal delivery platform and brings together a world-class team of scientists and engineers providing expertise for vaccine formulation, pre-clinical and clinical evaluations, fill/fit/finish packaging, nasal delivery devices and manufacturing scale-up," said Dr. Balaji Narasimhan, Director of the Nanovaccine Institute at Iowa State University.

Zeteo's ZEOx2 Delivery Platform includes nasal delivery devices to support powder and reconstituted powder to liquid vaccine formulations that can be either caregiver- or self-administered.

Timothy Sullivan, President of Zeteo Biomedical, said "We are honored to have been selected by the ISU Nanovaccine Institute to provide our technology and expertise in nasal drug delivery and packaging to support this critically important project to address the global health devastation caused by COVID 19."

Additional collaboration partners involved in the project include the Southwest Research Institute (San Antonio, TX), Skroot Laboratory, Inc. (Ames, IA), and the University of Iowa (Iowa City, IA). This is a fast track project and is expected to be completed by the end of the year.

About Zeteo Biomedical LLC

Zeteo Biomedical(TM) is a biomedical device technology company based in Austin, Texas. Zeteo provides patient-centric delivery device technology and unit dose fill/finish packaging for pharmaceuticals, biopharmaceuticals, biologics and botanicals for intranasal, nose-to-brain, ophthalmic, sublingual, and animal care product applications. For more information please visit the Zeteo website at: https://www.zeteobiomed.com/.

Media Contact
Cathy Diehl
Zeteo Biomedical LLC
+(1) 512-614-0144
zeteo@zeteobiomed.com

*LOGO link for media: https://www.send2press.com/300dpi/20-1117s2p-zeteo-biomedical-300dpi.jpg

Zeteo Biomedical LLC, Inc., a privately held medical device company, has partnered with the Nanovaccine Institute at Iowa State University to study a nasal SARS-CoV-2 vaccine. Zeteo will provide nasal delivery device technology and unit dose packaging utilizing its ZEOx2 Delivery Platform.

Related link: https://www.zeteobiomed.com/

EyeCare Optical Extends its Coverage of the Greater Knoxville Area with New Locations in Oak Ridge and Hardin Valley

KNOXVILLE, Tenn. /ScoopCloud/ -- Earlier this year, EyeCare Optical expanded its reach in the greater Knoxville area by opening its seventh area office-this one in Oak Ridge-right on the heels of its sixth location opening in Hardin Valley. It's part of a plan, says the company, to make comprehensive eye care readily available for greater Knoxville residents in their own neighborhoods.

The brainchild of the venerable 50-plus-year-old East Tennessee Ophthalmology practice of Drs. Campbell, Cunningham, Taylor & Haun, EyeCare Optical is a new generation of vision centers designed for the convenience of East Tennesseans. The goal, says the company, is to meet the growing demand for neighborhood-based eye care by bringing Board-Certified optometrists and licensed opticians to all key communities in Knoxville and the surrounding area.

"With these new offices, we can now service about 70% of the area with patients not having to drive any more than 10 minutes to reach an EyeCare Optical location," said Dr. Philip Campbell. "With EyeCare Optical, we combine convenience with the exceptional care we built our practice upon."

EyeCare Optical provides everything from routine eye examinations and prescriptions to an extensive selection of designer frames and lens options as well as popular sunglass options. Optometrists provide corrective-lens prescriptions and contact lens fittings. Plus, patients can receive next-level care that includes screenings for cataracts and other age-related eye conditions.

Patients can also be evaluated for LASIK(r) vision correction at any EyeCare Optical office, and Ophthalmologists specializing in retina, cornea, and other diseases are available with their parent practice. Because of the affiliation with Drs. Campbell, Cunningham, Taylor & Haun, an EyeCare Optical optometrist can easily refer a patient needing a higher level of care to Board-Certified Ophthalmologists.

"It's convenient, comprehensive eye care," said Dr. Campbell. "That has great appeal to many people."

He noted that EyeCare Optical offices also offer innovations like Optomap, diagnostic technology that can photograph the patient's retina, allowing eye doctors a detailed image that can be studied to identify problems or diseases early on. With Optomap, the patient doesn't have to have the dilation of his or her eyes needed for traditional retina exams, eliminating disruptions, discomfort, and downtime. The doctor and patient can review and discuss the image together, which gives the patient more information on personal eye health.

"We put new technology and new levels of care minutes away," said Dr. Campbell.

EyeCare Optical has 10 Optometrists and their locations include West Knoxville at Weisgarber Road (near the county's population center) Fountain City, Hardin Valley, Farragut, Oak Ridge, Maryville, Sevierville, and Bearden (Andes EyeCare Optical) locations.

New patients are welcome. To learn more, or to schedule an appointment, visit: http://www.eyecareoptical-knoxville.com/. Walk-in patients are also welcome at all locations.

Earlier this year, EyeCare Optical expanded its reach in the greater Knoxville area by opening its seventh area office-this one in Oak Ridge-right on the heels of its sixth location opening in Hardin Valley. It's part of a plan, says the company, to make comprehensive eye care readily available for greater Knoxville residents in their own neighborhoods.

Related link: https://www.eyecareoptical-knoxville.com/

Ombudsman Services Executive Director Named Woman of the Year by Congressman Garamendi

PLEASANT HILL, Calif. /ScoopCloud/ -- Ombudsman Services of Contra Costa, Solano and Alameda is pleased to announce that Executive Director Nicole Howell has been selected as a 2020 Woman of the Year by Congressman John Garamendi.

In an effort to recognize outstanding women serving in California's Third Congressional District, the Congressman annually invites individuals and organizations to submit nominations of those who have shown a commitment to improving quality of life through leadership and public service.

"This is a tremendous honor," Nicole said during the awards ceremony.

In the wake of the COVID-19 pandemic, Nicole and the Ombudsman team took to the front lines to distribute personal protective equipment to over 15,000 residents in long-term care. She also participated in efforts for residents' rights by collaborating with local media and testifying on behalf of a movement of residents and their families at the House Ways and Means Health Subcommittee hearing "Examining the COVID-19 Nursing Home Crisis" on June 25. During the height of COVID-19, OSCCSA completed nearly 300 facility consultations and close to 200 individual consultations, providing vital information and resources throughout Alameda County.

"I want to accept this award on behalf of all those people who are fighting the fight for seniors right now, particularly those in long-term care," Nicole said. "Thank you so much. This is beyond what I could have dreamed."

As the Executive Director for Ombudsman Services of Contra Costa, Solano, and Alameda (OSCCSA), Nicole is responsible for ensuring that the nearly 29,000 long-term care residents and their families have access to the highest level of care and respect and, above all, can live free of abuse and neglect.

Since becoming Executive Director, Nicole has grown OSCCSA's budget by nearly 600%, lowered the use of anti-psychotics in Contra Costa County by 10%, and increased facility coverage by unearthing the problems and issues that are being overlooked. She has helped spearhead many new programs in Ombudsman Services and beyond, including the Elder Justice Program Solano, Telephone Reassurance, and Friendly Visiting in Solano County, as well as Healthcare Career Pathways and Residents' Rights in Contra Costa.

About Ombudsman Services of Contra Costa, Solano and Alameda:

Ombudsman Services is the only organization mandated by law to make unannounced visits to long-term care facilities to ensure that residents are free from abuse and are receiving quality care. We have been aiding the community for more than 40 years, and all services are free of charge. We serve Contra Costa, Solano and Alameda counties with our team of highly trained Ombudsman staff and volunteers.

For more information, visit https://www.ccsombudsman.org/.

MEDIA-ONLY CONTACT:
Susie Hays
Susie@Q2Mark.com
760-458-9201

Ombudsman Services of Contra Costa, Solano and Alameda is pleased to announce that Executive Director Nicole Howell has been selected as a 2020 Woman of the Year by Congressman John Garamendi.

Related link: https://www.ccsombudsman.org/

Papa Inc. Adds Reliance to Its Growing List of Medicare Advantage Plans to Provide ‘Family on Demand’ to Their HMO Population

MIAMI, Fla. /ScoopCloud/ -- Papa Inc, the leading technology-enabled platform for companionship & assistance for older adults & families, today announced it has been selected by Reliance Medicare Advantage to provide services beginning January 1, 2021 to their Michigan HMO population in order to enhance their quality of life through the eradication of social isolation and loneliness.

Papa has created a new category of care through technology by turning a large supply of talent (students, stay-at-home parents and young professionals) into a new category of provider that Papa calls "Pals."

As a partner, Papa will provide Reliance HMO members a program that bridges the gap between generations and offers seniors a unique at-home experience that can enrich their lives and combat feelings of isolation and loneliness.

Papa "Pals" can provide help with:

* Companionship - Whether it is board games, great conversation, or just enjoying each other's company, Papa provides valuable interactions either virtually or in-person;

* Transportation - Whether it is door to door, or door through door, Papa provides transportation to medical appointments, volunteer or work engagements, the grocery store, or even a visit to the park for a change of scenery;

* Technology Assistance - Papa Pals can assist with technology such as cell phones, computers and tablets to make sure members are staying connected to family and friends;

* Light Chores - Changing seasons can bring opportunity for Papa Pals to assist with light chores around the home such as gardening, snow removal, food preparation

"Loneliness and social isolation have many negative effects on older adults, including issues associated with the lack of transportation, independence and technical savvy," said Founder and CEO Andrew Parker. "National Academies of Sciences, Engineering, and Medicine (NASEM) explains that more than one-third of adults aged 45 and older feel lonely, and nearly one-fourth of adults aged 65 and older are considered to be socially isolated. Considering the Census Bureau data that there will be 78 million people 65 and older by year 2035 compared to 76.7 million under the age of 18, we have an immediate responsibility to provide solutions that will result in positive long-term effects like lowering medical costs and improving their quality of life for this beloved population."

"Reliance chose Papa for their unique task-driven companionship services and mission to support families throughout the aging journey," said Jacob Nysson, Reliance COO. "We look forward to working with Papa to further evaluate our ageing members' needs and providing services to address those needs."

About Reliance

As Michigan's only doctor owned Medicare Advantage plans, Reliance Medicare Advantage is proud to provide southeastern Michigan residents on Medicare with a different kind of healthcare plan. For more information, visit: https://www.reliancemedicareadvantage.org/.

About Papa Inc

Papa is a platform of curated companions that provide support and assistance to older adults and families nationwide. Papa was founded in 2017 in Miami, FL. For more information, visit: https://www.joinpapa.com/.

* LOGO link for media: https://www.Send2Press.com/300dpi/20-0305s2p-papa-inc-logo-300dpi.jpg

Papa Inc, the leading technology-enabled platform for companionship & assistance for older adults & families, today announced it has been selected by Reliance Medicare Advantage to provide services beginning January 1, 2021 to their Michigan HMO population in order to enhance their quality of life through the eradication of social isolation and loneliness.

Related link: https://www.joinpapa.com/

Spodak Dental Group Celebrates American Diabetes Month with Complimentary Sleep Apnea Consultations

DELRAY BEACH, Fla. /ScoopCloud/ -- November is American Diabetes Month and the Spodak Dental Group team is offering complimentary sleep apnea consultations to help patients treat their sleep apnea so they can better control their diabetes. Studies show that about 71% of people with diabetes may have sleep apnea.

Characterized as a chronic condition wherein a person suffers from pauses in breathing or takes shallow breaths during sleep, people with sleep apnea can actually stop breathing for 10 seconds or even up to a minute, many times throughout the night. These pauses in breathing make it more difficult to manage diabetes because they have been associated with insulin resistance leading to higher blood sugar levels, glucose intolerance and type 2 diabetes. Research also shows that an increase in severity of sleep apnea is correlated with poorer glucose control.

"It is incredibly important for those who suffer from diabetes to accurately diagnose and treat their sleep apnea because managing their sleep apnea will help them to better manage their diabetes," said Dr. Tiffany Dudley, general dentist at the Spodak Dental Group and American Board of Dental Sleep Medicine Diplomate.

During the month of November, Dr. Dudley is offering complimentary sleep apnea screenings and 30-minute virtual consultations. For those who have a moderate to high risk of sleep apnea, the Spodak Dental Group offers many different oral appliances for treatment. Most appliances can be made with digital impressions and are a comfortable option for those who want to avoid a CPAP machine.

To schedule a complimentary, 30-minute virtual sleep apnea consultation, please visit http://www.sdgvirtual.com/.

About Spodak Dental

The Spodak Dental Group, a 2017 Inc. 5000 honoree, has evolved to become South Florida's premier, comprehensive dental facility, and comprises a world-class association of dental professionals poised to provide full-service dental care second-to-none in both scope and skill. The Spodak Dental Group team includes General and Restorative Dentists, Endodontists, Periodontists, Board Certified Oral and Maxillofacial Surgeons, Master Ceramic Artists and Anesthesiologists, as well as one of the nation's only in-office dental labs.

Spodak Dental Group is located at 3911 W. Atlantic Ave. Call or text (561) 303-2413 or visit https://www.SpodakDental.com for more information.

November is American Diabetes Month and the Spodak Dental Group team is offering complimentary sleep apnea consultations to help patients treat their sleep apnea so they can better control their diabetes. Studies show that about 71% of people with diabetes may have sleep apnea.

Related link: https://www.spodakdental.com/

2020 International Clostridioides difficile (C. diff., C. difficile) Virtual Conference and Health EXPO Nov. 14

TAMPA, Fla. /ScoopCloud/ -- C Diff Foundation announced today that the 8th Annual International C. diff. Virtual-Online Conference and Health EXPO will be a 5-1/2 hour online program with over fourteen international topic-experts dedicated in disciplines of healthcare, pharma, biotech, academia, and Government agencies.

Presenters will deliver data and discuss critical information on a leading Healthcare-Associated Infection (HAI), Clostridioides difficile, Gut Microbiome, Infection Prevention, and global healthcare-associated issues on November 14, 2020 with a live online program under the direction of IT professionals at WhiteHat Communications.

To learn more about this extraordinary conference, guest speakers, poster presentations, and the diverse topics being presented visit: https://cdiff2020.com/guest-speakers-1

All attendees will have the highest levels of online networking and learning opportunity at the Conference and Health EXPO and registration is complimentary this year. Save the date: November 4th and 5th, 2021 the 9th Annual conference will be hosted at the Boston Logan Hilton Hotel in Boston, Mass.

C Diff Foundation expresses their gratitude to Seres Therapeutics for being the conference Diamond Sponsor. Seres Therapeutics is appreciated for their continued support and partnering with the C Diff Foundation in promoting C. diff. Awareness worldwide. This activity has been supported by a medical educational Grant from Pfizer and the members of the C Diff Foundation are profoundly grateful.

Attendee Paul Feuerstadt, MD, FACG, AGAF stated "The level of detail and data presented has a wonderful balance for those with an interest in the scientific research and interested in the infection but also exceeds the expectations for those who are experts in the field wanting to share and exchange ideas with other thought leaders."

"I am excited to virtually meet and interact with everyone for the online extraordinaire C difficile foundation 2020 meeting. We will discuss all things C difficile and remember to tune in for my talk on the excitement of microbiome therapeutics for recurrent C difficile," stated Sahil Khanna, M.B.B.S., M.S.

The scientific data will be delivered through live virtual presentations and poster presentations at the 8th Annual International C. diff. Virtual Conference and Health Expo https://cdiff2020.com which coincides with the proclaimed; "November is Clostridioides difficile (C. diff., C. difficile) Awareness Month."

Scott Battles, VP of the C Diff Foundation stated, "We are profoundly grateful to the United States Governors for supporting our mission, along with our domestic and international partners."

November 18 - 24, 2020 Be Antibiotics Aware, a CDC educational effort, complements U.S. Antibiotic Awareness Week by providing partners with up-to-date information to help improve human antibiotic prescribing and use in the United States.

"None of us can do this alone, all of us can do this together."

About Clostridioides Difficile Infection (CDI)

Clostridioides (formerly Clostridium) difficile, also known as C. difficile or C. diff., is one of the most common causes of healthcare-associated infections in U.S. hospitals (Lessa, et al, 2015, New England Journal of Medicine). Recent estimates suggest C. difficile approaches 500,000 infections annually in the United States and is associated with approximately 20,000 deaths. (Guh, 2020, New England Journal of Medicine). Based on internal estimates including a recurrence rate of approximately 20%, we believe the annual incidence in the U.S. approaches 600,000.

About The C Diff Foundation:

C Diff Foundation, a 501(c)(3) established 2012, comprised of 100% volunteering professionals is dedicated at supporting public health through education and advocating for Clostridioides difficile infection (CDI) prevention, treatments, clinical trials, AMR, and environmental safety worldwide.

Listen to "C.diff. Spores and More" Tuesdays at 1 p.m. EST (www.cdiffradio.com) sponsored by Clorox Healthcare.

Learn more at: https://cdifffoundation.org/.

Follow C Diff Foundation on LinkedIn, Twitter, Facebook, and Instagram. Download "C diff and You" app from Apple and Google Stores.

Twitter @cdiffFoundation #Cdiff2020

Media Contact:
Kathy Bischoff
C Diff Foundation
kathy@cdifffoundation.org
Office: (727) 205-3922

IMAGE LINKS FOR MEDIA:

[1] https://www.Send2Press.com/300dpi/30-1111s2p-cdiff8th-splash-300dpi.jpg

[2] https://www.Send2Press.com/300dpi/20-1111s2p-Cdiff640-920Conf-300dpi.jpg

C Diff Foundation announced today that the 8th Annual International C. diff. Virtual-Online Conference and Health EXPO will be a 5-1/2 hour online program with over fourteen international topic-experts dedicated in disciplines of healthcare, pharma, biotech, academia, and Government agencies.

Related link: https://cdifffoundation.org/

Dementia Map Reinvents Access to Dementia Resources

PORTLAND, Ore. /ScoopCloud/ -- JADCOM Media LLC announced today that Lori La Bey of AlzheimersSpeaks.com and Dave Wiederrich of MemoryCafeDirectory.com have created Dementia Map(TM) at DementiaMap.com - the first Global Resource Directory and event calendar for families and professionals.

The two have taken a simple approach to the often difficult and frustrating process of finding dementia resources, with this free-to-use guide.

Dementia Map Global Resource Directory

There is a common obstacle faced by those diagnosed with a form of dementia, their family caregivers, and professionals seeking information about dementia resources. Many websites require a visitor to provide contact information prior to releasing resource details, which is often viewed by the consumer as uncomfortable and intimidating. Frequently, this is to provide referral fees to a "middleman" organization.

"Dementia Map has been a dream of mine for 36 years," Lori La Bey notes. That's when her 30-year journey with her mother's dementia started. She was totally shocked, frustrated and disturbed by the lack of resources available to those in need. "Even today, most medical professionals can't guide their patients to where they can find help. It's not their fault. Nothing like this existed prior to Dementia Map," she adds.

"We created DementiaMap.com to help families and those seeking resources, a direct connection to products and service providers. We wanted to do that in a non-threatening fashion," says Dave Wiederrich. "By creating a simple, direct, and friendly website, both families and professionals can utilize one tool to expand their knowledge base and options for care which are so badly needed. We have gone to great lengths to be clear and concise, knowing those who care have extremely limited time to search for resources."

Dementia Map Events Calendar

Another key element of the Dementia Map strategy is their comprehensive Events Calendar. An event is a valuable way for individuals living with dementia and those who provide care, to gain important information. By consolidating both in-person and virtual events into one global calendar, even more resources are made available.

Professionals and other event coordinators benefit as well. By having visibility to other events already planned, schedules can be strategically designed to avoid overlap and conflict. This can help increase attendance at in-person events, but also the growing base of online meetings.

The Dementia Map benefits extend to the broader healthcare industry as well. Free and economical plans are critical to level the playing field between large and small services. Families deserve all options so they can make the best possible choice for their loved one in an industry being hit hard by the COVID-19 pandemic. This enables brands large and small alike to more easily reach their target markets.

DementiaMap - http://dementiamap.com/ - is free for visitors to search for resources. It offers three ways for companies and professionals to become members of the site. A Starter Plan allows anyone to get the exposure they need and deserve at no cost. The Pro and Featured Plans are paid options with increasingly more promotional features and greater brand visibility throughout the site.

Follow Dementia Map on Twitter, Facebook, Instagram, and Pinterest. Find them at @demmapgrd.

Dementia Map is a joint effort between Lori La Bey of Alzheimer's Speaks, and Dave Wiederrich of Memory Cafe Directory. Dementia Map is wholly owned by JADCOM Media LLC, an online media publishing company based in Portland, Oregon.

MEDIA CONTACT:
David L. Wiederrich
CEO, JADCOM Media LLC
503.970.4426 (media only)
Dave@DementiaMap.com

JADCOM Media LLC announced today that Lori La Bey of Alzheimers Speaks and Dave Wiederrich of Memory Cafe Directory have created Dementia Map at DementiaMap.com - the first Global Resource Directory and event calendar for families and professionals.

Related link: http://dementiamap.com/

Siperstein Dermatology Group Offers Only DermaGraphix Digital Mole Mapping and Artificial Intelligence Tracking Analysis in South Florida

BOCA RATON, Fla. /ScoopCloud/ -- Siperstein Dermatology Group now provides the DermaGraphix digital mole mapping and artificial intelligence tracking analysis that allows for the earlier detection and treatment of melanoma, and with fewer biopsies. Siperstein Dermatology Group (Boca Raton and Boynton Beach Florida) has always been on the forefront of medical technology. The group prides themselves on always having the most up-to-date systems and new technology to help patients.

Siperstein Dermatology Group is the only private practice in Florida, and the entire Southeast United States, that is able to employ the DermaGraphix and artificial intelligence technology. DermaGraphix is the most innovative mole mapping system available and helps dermatologists to more easily spot new moles and track changes to patients' moles - one of the possible signs of melanoma.

"Melanoma, when found early, is curable. However, if detection is delayed, it can be fatal," said Robyn Siperstein, medical doctor and founder of Siperstein Dermatology Group. "Baseline mole mapping and AI analysis not only helps to detect melanoma much earlier, but has also been found in studies to reduce the number of biopsies needed."

DermaGraphix mole mapping and tracking analysis uses a high-resolution, professional, digital SLR camera, advanced software and whole body photography to map a patient's entire skin surface, creating a photographic baseline. Artificial intelligence is then utilized as a way to accurately identify any change in the size, color and shape of lesions, as well as document any new lesions.

In addition, this system has an attached dermatoscope, which allows dermatologists to visualize and photograph individual moles using magnification and polarized light to better detect subtle changes in these moles and patterns that could be consistent with melanomas.

"Mole mapping is used in most of the melanoma clinics in university hospitals and cancer centers," said Thomas Bialoglow of Canfield Scientific, the leading supplier of medical photographic equipment, software and computer systems for patient imaging in medicine and research. "The powerful DermaGraphix system, which is in use at [Memorial Sloan Kettering Cancer Center], is now only available at a few private practices in the United States."

Patients can take advantage of the DermaGraphix digital mole mapping and artificial intelligence tracking analysis by calling (561) 364-7774 or visiting https://www.sipderm.com/ to make an appointment.

About Siperstein Dermatology Group

Siperstein Dermatology Group is a privately-owned, state-of-the-art dermatology practice comprised of 10 board certified dermatologists, a board certified facial plastic surgeon, three physicians assistants and three laser technicians who pride themselves on providing the most up-to-date systems and technologies to treat all areas of dermatology including medical, surgical and cosmetic.

The team offers skin checks for early skin cancer detection, skin cancer treatment with Mohs surgery and plastic surgery closures, and treats all skin conditions such as acne, rosacea, psoriasis, hair loss, and more. They also offer a full array of cosmetic treatments including state-of-the-art lasers for resurfacing wrinkles, removal of brown or red spots and unwanted hair, microneedling with radiofrequency and PRP, filler and Botox injections, and hydrafacials with dermaplaning.

Siperstein Dermatology Group now provides the DermaGraphix digital mole mapping and artificial intelligence tracking analysis that allows for the earlier detection and treatment of melanoma, and with fewer biopsies. Siperstein Dermatology Group (Boca Raton and Boynton Beach Florida) has always been on the forefront of medical technology.

Related link: https://www.sipderm.com/

Super Bowl Champion Jeron Johnson has signed on as an Ambassador for CBD Move Free

BELLEVUE, Wash. /ScoopCloud/ -- Former Seahawk strong safety and Super Bowl XLVIII Champion Jeron Johnson has signed on as an Ambassador for CBD Move Free (https://cbdmovefree.com), a Washington State-based CBD company. "It is an honor to have Jeron onboard," states Jonas Roeser, CEO. "We look forward to his insight and support for our product refinement and educational outreach."

Johnson's backing is born of his personal experience. "Whether I am nursing an injury or preventing one," he says, "the Move Free products deliver for me. I have played for five NFL teams throughout my NFL career and have tried a number of products to soothe my injuries. And I have yet to come across an over-the-counter product that provides the reliable relief of the CBD Move Free products."

CBD Move Free's products consist of three CBD topical balms (of varying strength) that soothe pain; and a hemp-infused hand sanitizer. Each balm product is composed of full-spectrum CBD derived from hemp, and a number of other key ingredients. The three balms are delivered in roll-on containers and applied right on the skin. The three strengths are 500mg CBD, 1000mg CBD and a combo product featuring 500mg CBD and 150mg CBG (cannabigerol), an emerging ingredient related to CBD. Each balm product relaxes muscles and nerve cells, stimulates circulation, soothes pain, and eases inflammation -- while moisturizing the skin. The fourth product, a lemongrass hand sanitizer, is infused with 100mg of full spectrum hemp, under the brand Hemp Move Free.

Summarizing the company's mission, Roeser says, "Our aim was to create unique products that help you and your family move, enjoy, and achieve more."

Using the products couldn't be simpler, Roeser says. "To eliminate bacteria and moisturize your skin, our hand sanitizer is amazing; and to relieve tension, soreness, and inflammation, just apply one of our balms to targeted areas.

"Our company is partnered with our manufacturer and only uses third-party testing facilities to ensure top quality," Roeser continues. "Our products are sold in hundreds of locations nationwide. These range from doctors, drug stores, gyms and health and beauty stores, to premier golf clubs, and tennis facilities. Our products are also available through our website."

About CBD Move Free:

CBD Move Free (https://cbdmovefree.com) was developed to create unique hemp/CBD products. Each product is designed to maximize life activities by reducing pain and eliminating bacteria. Each product is a blend of natural ingredients infused with hemp/CBD to provide targeted relief. CBD Move Free is the DBA of JPS Products, LLC. JPS Products, LLC also operates Hemp Move Free and JPS Move Free.

DISCLAIMER: This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. All Products Contain .3% of THC Content or Less.

*PHOTO link for media: https://www.Send2Press.com/300dpi/20-1029s2p-jeron-johnson-300dpi.jpg
*Caption: Super Bowl champion Jeron Johnson.

Former Seahawk strong safety and Super Bowl XLVIII Champion Jeron Johnson has signed on as an Ambassador for CBD Move Free, a Washington State-based CBD company. "It is an honor to have Jeron onboard," states Jonas Roeser, CEO. "We look forward to his insight and support for our product refinement and educational outreach."

Related link: https://cbdmovefree.com/

Avila Herbals Announces Manufacturing and Research and Development Agreements with Phoenix Biotechnology

CHRISTIANSBURG, Va. /ScoopCloud/ -- Avila Herbals, a company specializing in novel botanical extraction techniques for both dietary supplements and pharmaceuticals, announced today that it has signed an exclusive global manufacturing agreement and a research and development agreement with Phoenix Biotechnology (San Antonio, TX), a company that has been exploring the health-related benefits of novel extracts of Nerium oleander for the past 25 years.

Avila Herbals began product development activities in the spring of 2020 and optimized several different proprietary extraction techniques. The company developed the formulation and the products and has scaled manufacturing in anticipation for a launch of several different products. Each product contains a unique extract from the Nerium oleander plant. Phoenix has filed several patent applications based on this work related to SARS-CoV-2 infection and the COVID-19 pandemic.

"We look forward to working with Phoenix Biotechnology. We are committed to developing and manufacturing several new oleander-based products with Phoenix," commented Dr. Richard Obiso, co-owner and CSO of Avila Herbals. "We are thrilled to be able to apply our research and manufacturing expertise to the development of these products."

The agreements support continued manufacturing so that the product can be made available in the United States and internationally. The agreements also cover the development and manufacture of a pharmaceutical, if clinical trials are approved by the US Food and Drug Administration (FDA); although the specific terms of the agreements were not disclosed.

Since Q2 CY2020, Avila Herbals and its partners have invested over $4.5 million dollars into the development and commercialization of these products in the New River Valley of Virginia. Avila has created more than 50 full-time jobs in just a few months to support the development and manufacturing of these products.

"Avila Herbals contributes to the economy of the New River Valley. The company's research and development of the potential health benefits of the extract of Nerium oleander is impressive, and we thank Avila and Phoenix for their commitment to the region and to the Commonwealth," said US Congressman Morgan Griffith.

According to Theresa Obiso, co-owner and CEO of Avila Herbals, "When we began our collaborations, we immediately scaled to meet this need; doing so here in Christiansburg allows us to leverage strong local relationships and build a world-class team."

"Avila Herbals' expansion is a significant win for our region's future and our growing economy," said Virginia Delegate Nick Rush. "Avila is a technology leader that exemplifies the New River Valley's entrepreneurial spirit," Delegate Rush continued. "I wish Avila Herbals much success as it moves forward to becoming one of SWVA's newest technology success stories."

About Avila Herbals

Avila Herbals has created a sustainable agriculture program in the New River Valley of Virginia that focuses on the production of the highest quality botanicals for use in nutraceuticals and botanical pharmaceuticals. The team uses supercritical carbon dioxide extraction as well as novel cryo-ethanol methods, and has launched several botanical preparations. Our passion is sustainable agriculture, organic techniques, and biodynamic farming practices. At Avila Herbals, we work hard to exceed regulatory standards, because we believe in sustainability and great quality. All of our products are manufactured in our GMP facilities.

About Phoenix Biotechnology

Phoenix Biotechnology, Inc. is a San Antonio, Texas-based biotechnology company that was incorporated in Texas in 2003 to develop promising agents from Nerium oleander with minimal or no side effects for targeted therapy in three areas: malignant tumor growth (an extract of Nerium oleander has been found to bind to discrete cellular targets in solid tumors in vitro and in vivo), neurological disorders (ischemic stroke, Alzheimer's disease, and Huntington's disease), and viral diseases. To date, Phoenix has identified potent antiviral activity against Ebola and Marburg viruses, cytomegalovirus, herpes simplex viruses, HIV and HTLV-1, and SARS-CoV-2.

For more information about Avila Herbals, please contact Avila Herbals at info@avilaherbals.com (preferred) or 1-540-808-2314.

On the web: https://avilaherbals.com/

*LOGO link for media: https://www.Send2Press.com/300dpi/20-1028x2p-avila-herbals-300dpi.jpg

Avila Herbals, a company specializing in novel botanical extraction techniques for both dietary supplements and pharmaceuticals, announced today that it has signed an exclusive global manufacturing agreement and a research and development agreement with Phoenix Biotechnology.

Related link: https://avilaherbals.com/

Progenabiome Shares New Data on Fecal Transplant, Sars-Cov-2 at ACG 2020

VENTURA, Calif. /ScoopCloud/ -- The American College of Gastroenterology (ACG) named Progenabiome "Outstanding Poster Presenter" for its poster: "Successful Bacterial Engraftment Identified by Next Generation Sequencing Following Fecal Microbiota Transplantation for Clostridioides difficile Infection," which will be presented virtually at the ACG Annual Scientific Meeting this week. From close to 2900 posters, only roughly 10% were selected as outstanding posters.

Progenabiome will also present a second poster: "Detection and Mutational Analysis of SARS-CoV-2 From Patient Fecal Samples by Whole Genome Sequencing." The ACG 2020 Meeting will be held virtually on October 23-28, 2020, and both poster abstracts and presentations will be available online in the ACG 2020 ePoster Hall.

Last year, Dr. Sabine Hazan, CEO of Progenabiome, shared groundbreaking data on C.Diff discovered through genetic sequencing at the 2019 ACG Meeting. She is looking forward to sharing newly found data on C.Diff and also COVID-19 at this year's event.

Dr. Hazan also recently published new findings from a phase 2 trial on Eosinophilic Gastritis and Duodenitis in the New England Journal of Medicine (NEJM.) As a leading clinical trials investigator who has overseen more than 150 clinical trials, Dr. Hazan is dedicated to research and producing validated, verified, and reproduced data.

Strategically placed as a genetic sequencing lab, site, contract research organization (CRO), and now sponsor, Progenabiome has 41 ongoing clinical trials related to immunity and disease, including five COVID-19 studies validating testing, prophylaxis, and at-home treatment protocols for the novel coronavirus.

For more information, visit:
https://progenabiome.com

https://clinicaltrials.gov

https://malibumicrobiomemeeting.com/

ACG ePoster Hall: https://eventscribe.com/2020/ACGPosters/

NEJM paper: https://www.nejm.org/doi/full/10.1056/NEJMoa2012047

Media Contact:
Stephanie Davis
sdavis@progenabiome.com

*IMAGE Link for Media: https://www.Send2Press.com/300dpi/20-1026s2p-Progenabiome-data-300dpi.jpg

The American College of Gastroenterology (ACG) named Progenabiome "Outstanding Poster Presenter" for its poster: "Successful Bacterial Engraftment Identified by Next Generation Sequencing Following Fecal Microbiota Transplantation for Clostridioides difficile Infection," which will be presented virtually at the ACG Annual Scientific Meeting this week.

Related link: https://progenabiome.com/

Uvilite Provides Hospital-Grade Sterilization Technology for Everyday Use

LOS ANGELES, Calif. /ScoopCloud/ -- Uvilite has developed a safe and powerfully effective ultraviolet sterilizing light technology for everyday residential use. Ideal for homes, cars and any other areas where germs are present, Uvilite uses hospital-grade technology that protects and empowers people to fight germs when and where they want to.

UV-C technology destroys up to 99.9 percent of bacteria, viruses and fungi by using safe and powerful ultraviolet light and it only takes a few minutes.

"Our flagship product, the Uvilite Torch, is the ultimate embodiment of everyday ultraviolet light sterilization," Charles Palao, a Uvilite co-founder, says. "We're thrilled that we've been able to 'consumerize' this industrial technology and bring it to the general population."

With built-in safety features, a dual-sterilization effect (from UV-C germicidal light and ozone generation), and a portable form factor, the Uvilite Torch is packed with the power of a sterilizing station, but in the form of a portable wand.

The FDA reports that, "UVC radiation is a known disinfectant for air, water and nonporous surfaces. UVC radiation has effectively been used for decades to reduce the spread of bacteria, such as tuberculosis. For this reason, UVC lamps are often called 'germicidal' lamps."

And, according to Uvilite, it's the small spaces that are the most concerning. For example, the germiest spot in a bathroom isn't the toilet, it's actually the toothbrush holder.

The Uvilite Torch is ideal for spaces up to 30 square feet. It's portable and rechargeable and ideal for places such as nurseries, bedrooms, bathrooms, kitchens, closets and cars. Its portable size also makes it easy for consumers to bring it with them to hotels, restaurants, gas stations and more.

Other products include the Uvilite Chamber, Uvilite Mini and Uvilite Mini+. All products are completely safe for items such as phones, keyboards, masks, wallets, keys, earphones, pacifiers and other objects because all products are chemical-free.

For more information: https://uvilite.com/

About Uvilite

Launched in 2020, Uvilite is a family-owned and operated business. Its mission is to provide safe and reliable products that protect and empower people. Customer service and support is its number one priority.

*PHOTO link for media: https://www.Send2Press.com/300dpi/20-1026s2p-uvilite-torch-300dpi.jpg
*Photo Caption: Uvilite Torch.

Uvilite has developed a safe and powerfully effective ultraviolet sterilizing light technology for everyday residential use. Ideal for homes, cars and any other areas where germs are present, Uvilite uses hospital-grade technology that protects and empowers people to fight germs when and where they want to.

Related link: https://uvilite.com/

The TMS Collaborative Celebrates its 1st Anniversary and Announces Clinic Expansion

EXETER, N.H. /ScoopCloud/ -- In September 2019, Dr. Paul Belliveau and partners launched The TMS Collaborative as a way to bring the cutting-edge technology of TMS to New Hampshire and beyond. TMS therapy is an FDA-approved, safe, and non-invasive treatment for patients suffering from Major Depressive Disorder (MDD).

The treatment consists of gentle pulses targeted at the areas of the brain that are known to be involved with depression. Approximately 40% of patients diagnosed with MDD experience little to no relief using antidepressants, and often experience a long list of side effects. TMS Therapy, however, has few known side effects, is covered by most insurance plans, and up to 60% of patients respond positively to treatment, while over half achieve a complete remission of their depression symptoms. Of the patients that The TMS Collaborative has treated this year, 80% have experienced improvement and relief from MDD.

Co-Founder and Medical Director of the TMS Collaborative, Paul Belliveau, MD, has been practicing in Exeter, NH for over 20 years and is Board-Certified by the American Board of Psychiatry and Neurology in Adult Psychiatry. Prior to practicing in Exeter, Dr. Belliveau was a physician with the United States Army, and practiced at Walter Reed National Military Medical Center.

"We are pleased to be able to bring this FDA approved treatment to Seacoast New Hampshire and surrounding areas of New England. Our patients have responded well to TMS and have found relief from their depression when antidepressants were not working for them. I continue to be impressed at how effective TMS is for many people that have suffered with depression for years," says Belliveau.

A year in, and many patient success stories later, the TMS Collaborative is expanding. "We are excited to announce that we are moving to a larger location in December. Our new location at 9 Hampton Road in Exeter will allow us to add additional TMS treatment rooms to better serve patients," says Wayne Barrows, co-founder and Director of Provider Operations. The clinic will continue to treat patients at its Exeter, NH location leading up to the grand opening.

ABOUT THE TMS COLLABORATIVE

The TMS Collaborative is dedicated to providing exceptional patient care and treatment of depression with TMS Therapy. The team at The TMS Collaborative brings over 25 years of experience in delivering the highest quality care in a welcoming clinical environment. To learn more about TMS and the Exeter, NH-based clinic, visit https://tmscollaborative.com/

Contact:
Email: findsupport@tmscollaborative.com
Phone: 603-988-2561

In September 2019, Dr. Paul Belliveau and partners launched The TMS Collaborative as a way to bring the cutting-edge technology of TMS to New Hampshire and beyond. TMS therapy is an FDA-approved, safe, and non-invasive treatment for patients suffering from Major Depressive Disorder (MDD).

Related link: https://tmscollaborative.com/

Pure Protein, LLC to Exhibit and Preview New Website at the American Society for Histocompatibility and Immunogenetics (ASHI) 46th Annual Meeting

OKLAHOMA CITY, Okla. /ScoopCloud/ -- Pure Protein, LLC (Pure Protein) an HLA company that has developed comprehensive analytical capabilities in the field of human leukocyte antigen (HLA) immunology and an approach to produce soluble forms of the HLA molecule (sHLA), announced today that it will be an exhibitor at the ASHI VIRTUAL ANNUAL MEETING, October 19 - 21, 2020, where the Company will be previewing its soon to launch website https://www.hlaprotein.com/.

This new website will offer academic and commercial researchers access to individual HLA reagents to detect, profile, and monitor allele-specific immune responses, as well as HLA peptide epitope binding services to aide in improving the design of vaccination and therapeutic targeting strategies.

Rico Buchli, Ph.D., Pure Protein's Director of Research commented, "For over 20 years, Pure Protein has provided technology and expertise to advance novel therapies and diagnostic tools for applications in transplantation, oncology, autoimmunity, and infectious disease."

He added, "We are excited to exhibit at ASHI 2020 and share the news about hlaprotein.com where we will soon be offering researchers 126 Class I and 154 Class II proteins in both unmodified and biotinylated forms, as well as access to Pure Protein's peptide validation, screening and mapping services."

About Pure Protein, LLC

Pure Protein, L.L.C. is a biotechnology company focused on the development and commercialization of proprietary technologies related to the human leukocyte antigen (HLA) system, formed and exclusively licensed from the University of Oklahoma in 1999. Pure Protein, in conjunction with its affiliates and subsidiaries, aims to bring novel therapies and diagnostic tools to patients across a wide range of application areas spanning from therapeutic development in the fields of oncology, autoimmunity, and infectious disease, to antibody mediated rejection in transplantation. Visit: https://www.hlaprotein.com/.

Pure Protein is funded and managed by Emergent Technologies, Inc. an innovation solutions and technology commercialization leader headquartered in Austin, Texas. Visit: https://emergenttechnologies.com/.

Link to event information: https://www.ashi-hla.org/page/Meetings_Annual

Pure Protein, LLC (Pure Protein) an HLA company that has developed comprehensive analytical capabilities in the field of human leukocyte antigen (HLA) immunology and an approach to produce soluble forms of the HLA molecule (sHLA), announced today that it will be an exhibitor at the ASHI VIRTUAL ANNUAL MEETING, October 19 - 21, 2020.

Related link: https://www.hlaprotein.com/

Hawaii’s First N-95 Mask Factory Opens Saturday, Oct. 17, 2020 in Kona

KONA, Hawaii /ScoopCloud/ -- Kona Mask Co. LLC, located in Kailua-Kona near Costco, will begin producing N-95 and flat-pleated masks using two automated machines. "We can produce 1 million masks every 3 weeks made right here in Hawaii," says Nicolas Garcia, CEO of Kona Mask.

Garcia saw the need for a local manufacturer to provide PPE rather than one based thousands of miles away.

Garcia adds, "We are inviting Mayor Harry Kim, members of the Coronavirus Task Force, government officials, and local leaders who helped inspire this concept, to walk through the factory on Saturday, October 17 at 10 a.m."

For further information, contact Nicolas Garcia, 808-365-6989 or email pilot3155@gmail.com

Factory address: 73-4820 Kanalani Street, Bay 9, Kailua-Kona, HI 96740

Other newsworthy items:

* Captain Nicolas Garcia retired from United Airlines on April 1, 2020 after 46 years as a pilot.

* The mask factory was inspired after the Pandemic was declared and Garcia could not find a mask for his fiancé, Amy Colombo, a United Airlines flight attendant.

* The funding came from Garcia selling his home and retirement savings.

* Garcia ran a successful airline soap factory during the 1980s AIDS Crisis.

* The factory will be staffed by locals with manufacturing experience.

* The factory mural was painted by Katana Leigh and will be unveiled on Saturday.

More information: https://konamaskco.com/

*PHOTO link for media: https://www.Send2Press.com/300dpi/20-1014s2p-kona-mask-factory-300dpi.jpg

*Photo caption: CEO Nicolas Garcia and United Airlines flight attendant Amy Colombo poised to make millions of N-95 masks at The Kona Mask Co.

Kona Mask Co. LLC, located in Kailua-Kona near Costco, will begin producing N-95 and flat-pleated masks using two automated machines. "We can produce 1 million masks every 3 weeks made right here in Hawaii," says Nicolas Garcia, CEO of Kona Mask.

Related link: https://konamaskco.com/

Colorado Doctors of Optometry Announce Public Health Initiative to Keep Eye Emergencies Out of Emergency Rooms This Winter

DENVER, Colo. /ScoopCloud/ -- Doctors of optometry across Colorado, 2020 Eyes Colorado, and the Colorado Optometric Association (COA) have launched an October awareness initiative to educate Coloradans on Eye Emergencies: Where to Go and What to Do. This health information is currently important for Colorado communities and populations vulnerable to COVID-19 as the state approaches a possible surge in COVID-19 cases during winter.

The HPI analysis of Healthcare Cost and Utilization Project (HCUP) data shows that eye emergencies make up 1% of emergency room cases and of those reported cases 98.9% could have been handled by a local optometrist in clinic or via telehealth (*note 1). Many practices offer after hours care to address eye care emergencies making it even easier for patients to avoid emergency rooms.

COA Board President, Dr. Tom Cruse says, "During the March/April shutdown our doctors of optometry were able to stop most eye emergency cases from going to urgent care and emergency facilities, which clearly assisted in slowing the virus spread and reducing individual exposure. As usual, optometrists still have the ability to treat emergency eye cases and we want every Coloradan to know how to use our emergency services for their own health and safety."

The CDC National Syndromic Surveillance Program (NSSP) reported that overall emergency room visits declined 42% early in the pandemic, but the viral infection cases quadrupled making emergency facilities a potential risk for many Coloradans including populations that are more vulnerable to a viral infection (*note 2). Optometry's vulnerable patient population is impacted by diabetes, hypertension and cardiovascular disease, which are known to complicate COVID-19 cases (*note 3).

The October public health initiative is taking place on Facebook, Instagram and Twitter using #2020EyesColorado and at 2020EyesColorado.org. Colorado optometry practices across the state have also geared up to join the initiative on social media to help spread the word in their own communities.

To learn more about what to do in an eye emergency, read the newly released 2020 Eyes Colorado article Eye Emergencies: Where to Go and What to Do! - https://2020eyescolorado.org/eye-emergencies-pr/

You will learn:

* Symptoms that need immediate attention from an optometrist

* Symptoms that need an eye exam soon

* Emergencies an eye doctor can treat and what to do at home

* How to find an optometrist

About the Colorado Optometric Association (COA):

The Colorado Optometric Association (COA) is the professional organization of optometrists in Colorado. Over 600 Colorado Doctors of Optometry are voluntary members of the Association. COA has also launched a public health campaign called 2020 Eyes Colorado.

Since 1892, the COA has assisted its members in providing the highest standard of professional care to their patients by sponsoring continuing education programs for doctors, advocating in local and state governments for programs and laws that represent patients' best interests, and providing information for the public. For more information, please visit http://www.visioncare.org/ or call 303-863-9778.

References
*Note 1: https://www.aoa.org/documents/HPI/HCUP%20HPI%20December_2019.pdf
*Note 2: https://www.cdc.gov/nssp/index.html
*Note 3: https://www.aoa.org/AOA/Documents/Advocacy/HPI/Emergency%20Department%20Diversion%20Brief.pdf

Doctors of optometry across Colorado, 2020 Eyes Colorado, and the Colorado Optometric Association (COA) have launched an October awareness initiative to educate Coloradans on Eye Emergencies: Where to Go and What to Do.

Related link: https://colorado.aoa.org/

‘Battered American Syndrome’ is Creating a New Mental Health Crisis According to Psychotherapist Podcaster Dr. Stephanie Knarr

LAUREL, Md. /ScoopCloud/ -- Dr. Stephanie Knarr first started using the term "Battered American Syndrome" on a recent episode of her Podcast: Dr. Stephanie Show's Podcast. In addition to the mental health crisis caused by COVID isolation, symptoms of Battered American Syndrome are common, putting Americans at an even greater risk for suicide.

COVID pressures have put more Americans at risk for mental health episodes, and suicide rates have increased dramatically since March.

In addition, Dr. Stephanie Knarr says she also sees many Americans with symptoms that are not unlike Battered Woman's Syndrome. Most people are familiar with symptoms of Battered Woman's Syndrome: feelings of helplessness, panic attacks, lowered self-esteem, and damaged relationships with friends and family. These symptoms are common among women who are in a mentally abusive relationship with an intimate partner who gaslights her, threatens to take away her livelihood, and possibly even physically assaults her.

Many Conservative Americans are experiencing these symptoms because of being mentally abused in the following ways:

* Many Liberals are emotionally abusing Conservative family members by not speaking to them due to differing political views.

* Liberals verbally abuse Conservatives via name-calling - calling them a racist or Nazi on social media or within other forums

* Gaslighting and deceptiveness from the Liberal Media is common

* Fear of losing a career or job due to observation that other Conservatives have lost careers for voicing a Conservative opinion

According to Dr. Stephanie Knarr, "Americans who were already more at risk for a mental health episode due to COVID are now even more at risk due to cumulative fear, intimidation, and gaslighting tactics from the Left. I do not see these problems going away after the election regardless of who wins."

The podcast episode from Dr. Stephanie Show's Podcast about Battered American Syndrome can be found wherever people download podcasts and on Spotify at https://open.spotify.com/episode/1tETzqMf6F8y5eQqaavepA

Conservative Americans are currently underserved due to fear of being stigmatized and misunderstood by Liberal Therapists. Dr. Stephanie Weiland Knarr recently launched the National Directory for Conservative Therapists and Mental Health Professionals at https://www.conservativetherapists.com/ so that Conservative Americans can more easily start to find Conservative therapists in their region.

MEDIA ONLY CONTACT
Stephanie Weiland Knarr, Ph.D., LCMFT
CEO, Stephanie Weiland LLC
+1-301-219-3397
stephanie@drstephanieonline.com
https://www.drstephanieonline.com/

*PHOTO link for media: https://www.Send2Press.com/300dpi/20-1013s2p-dr-weiland-knarr-300dpi.jpg
*Caption: Dr. Stephanie Weiland Knarr.

Dr. Stephanie Knarr first started using the term "Battered American Syndrome" on a recent episode of her Podcast: Dr. Stephanie Show's Podcast. In addition to the mental health crisis caused by COVID isolation, symptoms of Battered American Syndrome are common, putting Americans at an even greater risk for suicide.

Related link: https://www.drstephanieonline.com/

PainExam Launches New Ultrasound Interventional Pain Management CME Live Webinar Event Training Series

NEW YORK CITY, N.Y. /ScoopCloud/ -- PainExam, a prestigious CME certified pain medicine board review platform, develops new and exclusive Ultrasound Pain Management CME Courses, schedules next live CME webinar event for Oct. 18, 2020.

Physicians who treat pain, such as pain medicine specialists, ER doctors, Physiatrists, Anesthesiologists, Regenerative Medicine Specialists, Neurologists, Orthopedics, etc. can all benefit PainExam's new and exclusive "Ultrasound Guided Interventional Pain Management CME Live Webinar Event," hosted by Dr. David Rosenblum, Oct. 18.

Topics to Be Covered in Future Interventional Pain Management Ultrasound CME Events- Occipital Nerve Block, Paravertebral Nerve Block, Spine, Suprascapular Nerve Blocks, TAP Blocks, Ilioinguinal Nerve Blocks, Popliteal/Sciatic Nerve Blocks, Brachial Plexus Nerve Blocks, Joints, Tendons, Fascial Planes, Peripheral Nerve Stimulation, Caudal Epidurals, Selective Nerve Root Blocks, Cluneal Nerve Blocks, Ganglion Impair Blocks, Stellate Ganglion Blocks, Brachial Plexus Blocks, Joint Injections, Billing and Regenerative Medicine Covered, plus much more!

David Rosenblum, MD, the Director of Pain Management at Maimonides Medical Center in Brooklyn, brings over 15 years of experience performing Ultrasound Guided Pain Procedures, and has over 10 years of experience preparing well over three-thousand pain physicians nationwide for the pain boards.

Also the Creator of PainExam and the PainExam podcast, AnesthesiaExam, PMRExam Boards Reviews, Course Director for the PainExam ASIPP Regenerative Medicine Course and Ultrasound Guided Interventional Pain Course, Dr. Rosenblum will be presenting a series of "to be announced" Webinars, Online Tutorials, and Live Training Events focused on integrating Ultrasound technologies into an Interventional Pain Practice, Regenerative Medicine Practice, Regional Anesthesia Program, or Emergency Room Protocol.

Dr. Rosenblum along with PainExam, both support and actively collaborate with multiple state, national, and international medical societies and pain societies such as; ASIPP, NYSIPP, EPA, NANS, ASPN and most recently, WAPMU.

Office based Pain Physicians, Physiatrists, Emergency Room Physicians, Anesthesiologists, Neurologists and Orthopedics who treat pain, utilize Neuromodulation, and use PRP, Bone Marrow Aspirate or any other Biologics can and will benefit from this live Ultrasound CME event.

To register for this exclusive ultrasound CME event: https://painexam.com/events/ultrasound-guided-interventional-pain-course-oct-18/

About PainExam

Online Pain Management Board Review for the ABA, ABPM, ASIPP and WIP FIPP/CIPS, MOCA, and primary certification in pain management. 40 CME credits available for participation. Learn more at: https://www.PainExam.com

Social Links

https://www.facebook.com/PainExam/

https://twitter.com/painexams

https://www.instagram.com/painexam/

https://www.linkedin.com/company/painexam

https://www.pinterest.com/painexam

https://www.youtube.com/user/DocRosenblum/videos

MULTIMEDIA:

*VIDEO (YouTube): https://youtu.be/_O_bO7NnS34

*IMAGE link for media: https://www.Send2Press.com/300dpi/20-1009s2p-painexam-cme-event-300dpi.jpg

PainExam, a prestigious CME certified pain medicine board review platform, develops new and exclusive Ultrasound Pain Management CME Courses, schedules next live CME webinar event for Oct. 18, 2020.

Related link: https://painexam.com/